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INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 10  
FIRST PART: Pulmonary dysfunction in the critically ill 
 
In critically ill patients, respiratory problems are common and complicate the course 
of the disease. Among other diseases, this has been described in septic patients 
(1,2), trauma patients (3,4) and in patients after cardiac and aortic surgery (5-8). 
These conditions are associated with an elevated risk of developing acute lung injury 
(ALI) or Adult Respiratory Distress Syndrome (ARDS). ALI and ARDS are 
characterized by severe arterial hypoxemia, a reduction of lung compliance and 
bilateral diffuse alveolar infiltrations on the chest X-ray. First, the diagnosis of both 
conditions is defined by the American-European Consensus Conference (AECC) 
criteria. According to these criteria, the diagnosis of ALI includes the presence of a 
PaO2/FiO2 gradient < 300 and the diagnosis of ARDS a PaO2/FiO2 gradient < 200 mm 
Hg, regardless of the positive end-expiratory pressure (PEEP), together with the 
presence of bilateral infiltrations on the chest radiograph. Furthermore, a pulmonary 
capillary wedge pressure (PCWP) <18 mm Hg and the absence of left atrial 
hypertension are necessary to exclude pulmonary dysfunction resulting from 
cardiogenic pulmonary edema, associated with increases in hydrostatic pressures 
(9). Second, the so-called lung injury score (LIS) incorporates gas exchange, 
radiological and lung mechanical abnormalities by taking the level of PEEP into 
account, together with the lung compliance being calculated as tidal volume/(plateau 
pressure-PEEP), the PaO2/FiO2 gradient and radiographic findings (number of 
quadrants with alveolar opacities). The LIS score ranges between 0 and 4, with 
values above 2.5 indicative of ARDS and between 0 and 2.5 of ALI (10). 
 
Microvascular permeability 
Injury of the alveolar-capillary membrane is a hallmark of ARDS, leading to increased 
permeability (11). Indeed, the presence of risk factors for developing ARDS is 
associated with increases in microvascular permeability (5,8,12-19), as well as the 
presence of pulmonary edema (20-24). Techniques for the measurement of 
endothelial permeability include the measurement of the flux of radiolabelled proteins 
between the intra- and extravascular compartment, for instance 67Gallium (Ga) 
binding to transferrin (12-19). The so-called pulmonary leak index (PLI) has been 
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demonstrated to be specific and sensitive for an increase in pulmonary endothelial 
injury, associated with the presence of ALI and ARDS (12-14,18) and to be a 
valuable tool in the differential diagnosis between cardiogenic pulmonary edema and 
non-cardiogenic edema (14), two conditions with different treatments. However, the 
precise contribution of increased microvascular permeability to the genesis of lung 
edema in these patients has not been established and the PLI may be normal in 
some patients with ALI or ARDS (1). Some studies using PET-scan to evaluate 
extravascular densities as a measure of EVLW, in relation to microvascular 
permeability, which was measured as the pulmonary transcapillary 68Ga-transferrin 
escape rate, did not find a relationship between both variables (25-27). Moreover, 
microvascular permeability was found to inversely correlate with gas exchange in 
some studies (4,28), but not in others (5). 
 
Radiological consolidations and the detection of pulmonary edema 
Chest opacities can be evaluated with either computed tomography (CT) scanning or 
chest X-rays. Possible causes of opacities include atelectasis and lung edema. 
Atelectasis is a common finding in up to 50% of the patients at risk for ARDS and 
contributes to radiographic abnormalities (7,29-32). Gas exchange abnormalities 
resulting from atelectasis may be difficult to differentiate from a fall in oxygenation 
resulting from increased permeability and pulmonary edema. This may be of 
importance, as the former may benefit from recruitment maneuvers, in contrast to the 
latter (33,34). However, radiological detection and particularly chest X-ray, have 
been shown to be insensitive for the accumulation of extravascular lung water 
(EVLW) or to detect changes in EVLW (24,35-39). In conclusion, both CT scanning 
and chest X-ray are of limited value in differentiating the primary cause of chest 
opacities, i.e. lung edema, atelectasis or pleural effusions (24,35,36,38-40). 
Moreover, transporting a patient in unstable conditions to perform a CT-scan is often 
not feasible.  
 
Another possibility of measuring extravascular lung water, as a measurement of lung 
edema, includes the thermal-dye dilution technique (36,41-45), which consists of 
injecting ice-cold indocyanine green (= intravascular tracer) through the central 
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venous catheter with concomitant detection in the femoral artery. The dilution curves 
of both tracers are obtained, allowing calculation of the extravascular thermal 
volume, as an estimate of the EVLW (45). However, whereas radiography evaluates 
lung densities independently from the pulmonary blood flow, the measurement of the 
thermal-dye EVLW may depend on blood flow and therefore may underestimate 
pulmonary edema in the presence of pulmonary embolism or direct lung injury, 
associated with perfusion deficits (21,46-49). Furthermore, if the presence of EVLW 
with help of the thermal-dye technique is established, the consequences in terms of 
a disturbed gas exchange are far from resolved. A relationship between EVLW and 
gas exchange disturbances has been found in some studies (23), but not in others 
(41,42). 
 
In conclusion, pulmonary dysfunction in patients at risk for ALI or ARDS includes a 
compromised gas exchange, lung mechanical and radiological abnormalities. These 
abnormalities can be explained by either increases in pulmonary microvascular 
permeability and the development of lung edema or the presence of atelectatic 
areas. Although risk factors for changes in pulmonary function in patients at risk for 
ARDS have been identified, the incidence and interrelation of these pulmonary 
abnormalities is unclear.  
 
OBJECTIVES AND OUTLINES 
 
In the first part of our thesis, we studied the incidence and pathogenesis of pulmonary 
ventilatory and radiographic abnormalities in three subsets of patients at risk for 
developing ALI and ARDS, i.e. post-operative cardiac surgery patients, aortic surgery 
patients and septic patients.  
 
Cardiac surgery is a risk factor for post-operative pulmonary complications, associated 
with a compromised oxygen diffusion (7,50) and the occurrence of ARDS (incidence 
0.4%) at the end of the spectrum, increasing the incidence of mortality in cardiac 
surgery patients from 5% up to 15% (51,52). First, an inflammatory response was 
shown to increase pulmonary microvascular permeability in some studies (5,12), but 
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not in others (53). Second, the use of cardiopulmonary bypass may be associated with 
increases in extravascular lung water (20,22), but this was not confirmed by other 
studies (36,54). Finally, mechanical conditions may be confounding factors in 
evaluating gas exchange, i.e. pleural lesions, sternotomy, harvest of mammary 
arteries, muscle paralysis, changes in compliance and anesthesia may cause 
disturbances of respiratory mechanics (22,32,55-58). Taken together, both the 
incidence and interrelation of the different manifestations of pulmonary injury is unclear 
in post-operative cardiac surgery patients. 
 
In chapter 2 we evaluated the occurrence and causes of pulmonary edema in 
mechanically ventilated patients within three hours after cardiac surgery involving 
cardiopulmonary bypass. In all patients we measured EVLW, capillary permeability, 
gas exchange, radiographic and ventilatory parameters.  
 
Like cardiac surgery, aortic surgery is known to be complicated by impaired gas 
exchange and prolonged mechanical ventilation, associated with an increased 
mortality (6,8,59,60). In a previous study, we have demonstrated the importance of 
aortic clamping in the pathogenesis of endothelial injury, as aortic surgery with 
clamping was associated with an increase in pulmonary microvascular permeability, 
in contrast to peripheral vascular surgery (13,18). This type of surgery generates 
pulmonary injury, including ischemia/reperfusion injury, related to the clamping and 
unclamping of the aorta causing a systemic inflammatory response which results in 
neutrophil accumulation and upregulation of adhesion molecules leading to 
increased microvascular permeability (6,8,13,18,61). However, after major vascular 
surgery, mechanical factors may contribute to pulmonary dysfunction, e.g., as a 
result of a compromised chest compliance (59,60). Insight in the interrelations of 
pulmonary abnormalities in these patients can help to design therapeutic measures 
to better prevent pulmonary dysfunction.  
 
In chapter 3 we studied the mechanisms of pulmonary ventilatory abnormalities in 
relation to EVLW and capillary permeability in patients after major vascular surgery 
and ischemia/reperfusion. 
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In sepsis, known to be a major risk factor for ALI/ARDS, acute lung injury 
progressing to ARDS, can result from pneumonia or extrapulmonary causes. The 
degree of pulmonary dysfunction and lung injury, being of pulmonary (direct) or 
extrapulmonary (indirect) origin, may depend on the etiology and even may represent 
two distinct entities (33). The primary origin possibly predicts the effectiveness of 
treatment. In some studies, indirect forms of ARDS were associated with alveolar 
collapse and atelectasis, and thus may benefit from recruitment maneuvers, in 
contrast to direct forms of ARDS, associated with alveolar and lobar consolidations 
(33,62). Others however, claimed that the benefit of alveolar recruitment was less 
dependent on the cause of ARDS than the morphological abnormalities on CT 
scanning (63). Taken together, pulmonary or extrapulmonary causes of ARDS may 
differ in the degree of pulmonary injury and this distinction may have important 
therapeutic consequences.  
 
In chapter 4, we studied the relation between gas exchange abnormalities and 
increased permeability edema in sepsis-associated acute lung injury/acute respiratory 
distress syndrome (ALI/ARDS) by pneumonia or an extrapulmonary origin. 
 
SECOND PART: Fluid loading in the critically ill 
 
Hypovolemia is relatively common after major surgery, including cardiac and 
vascular surgery, and is associated with major fluid shifts and hypotension (64-66). 
Fluid loading is the mainstay of treatment and goal-directed fluid therapy may even 
reduce intensive care unit and hospital lengths of stay (66). Different infusion fluids, 
crystalloids and/or colloids can be used to treat hypovolemia and are described in 
several reviews. These fluids may differ with respect to osmolarity, molecular weight 
and substitution, dispersion, metabolism, intravascular persistence and consequent 
plasma volume expansion (67-69). The colloid-crystalloid controversy refers to the 
ongoing debate on the relative merits and detriments of resuscitation from 
hypovolemia with infusion of either colloids or crystalloids. Meta-analyses suggest no 
beneficial or even a detrimental effect of colloids versus crystalloids (70-74). 
Furthermore, a recent meta-analysis suggested an increase in mortality, associated 
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with the use of albumin (75). However, these conclusions were heavily criticized by 
others (76). Potential detrimental consequences of resuscitation include intravascular 
volume overload, pulmonary edema, increased myocardial water content, 
gastrointestinal ischemia and systemic edema (77). 
 
One of the major issues in the crystalloid-colloid controversy is the importance of the 
plasma colloid osmotic pressure (COP). The COP will be maintained or may even 
increase by the infusion of colloids and will be lowered by the infusion of crystalloids. 
It is unclear whether an increase in COP, associated with the infusion of colloids is 
accompanied by a greater speed and extent of plasma volume restoration as 
compared to crystalloids. Furthermore, the relative risks of fluid types to evoke 
pulmonary edema is unknown. By maintaining the COP, in contrast to crystalloids, 
colloids would prevent the development of pulmonary edema (72-74). However, 
possible side effects are disfavoring the use of colloids, including coagulopathies or 
anaphylactoid reactions and transmission of viral diseases (78,79).  
 
Myocardial function and the effect of fluids 
In clinical practice, volume status is frequently evaluated by measuring filling 
pressures, for instance the pulmonary capillary wedge pressure (PCWP) or central 
venous pressure (CVP) (80). These pressures however, are not very specific to 
assess preload or the volume expanding effect of fluid infusion. Indeed, filling 
pressures depend on blood volume, but also on vascular contractility, and 
myocardial function. Direct blood volume measurements, including intrathoracic 
blood volume index (ITBVI) and global end-diastolic volume index (GEDVI), are 
supposed to be better indicators of volume status, but not often used in clinical 
practice (45,81-83). Crystalloids and colloids often have been compared in their 
effects on cardiac output, most studies using filling pressures as endpoints of 
resuscitation. Some studies suggested for a given rise in filling pressure, no 
differences in the effect on cardiac output between fluid types (84-86), although 
higher volumes of crystalloids were needed to achieve the study endpoint. The ratio 
of crystalloid to colloid fluid volume to restore and maintain intravascular filling varied 
between 1 and 5 (74,85-91). However, other studies demonstrated differences in 
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fluid responses between resuscitation fluids, colloids resulting in a higher cardiac 
index (CI) for a given increase in filling pressures as compared to crystalloid, 
suggesting differences in cardiac contractility (92,93). Some studies comparing 
artificial colloids with albumin even suggested better myocardial performance with 
artificial colloids as compared to resuscitation with albumin (94-96).  
 
Fluids may interfere with cardiac performance, independently from plasma volume 
expansion and increases in preload. Colloids were shown to decrease endothelial 
swelling and myocardial parenchymal injury (86) and to reduce myocardial 
ischemia/reperfusion injury (97). Furthermore, albumin was described to have a 
negative inotropic effect in injured patients (98), but a positive inotropic effect in 
cardiac surgery patients (99). Finally, in animal models of cardiac surgery, several 
studies suggest that the type of prime solution affects the amount of myocardial 
edema (100-103), which may influence left ventricular compliance and performance.  
 
Fluids and pulmonary function 
Plasma volume expansion and myocardial dysfunction may increase hydrostatic 
pressures in the pulmonary circulation, favoring fluid filtration and ultimately leading 
to interstitial lung edema and impaired gas exchange. Furthermore, an increase in 
microvascular permeability, as found in patients after cardiac or vascular surgery 
(12,13,18), decreases the gradient in COP between the intravascular and interstitial 
compartment. This gradient may be important in preventing the genesis of pulmonary 
edema. Colloids and crystalloids have been compared in their effects on pulmonary 
function, without finding differences as measured by shunting and/or gas exchange 
in patients with severe pulmonary insufficiency (104), after vascular surgery (88) or 
cardiac surgery (105). Direct measurements of EVLW however, with help of the 
thermal-dye dilution technique for instance, are scarce. In cardiac surgery patients, 
crystalloids and colloids used as prime solutions for cardiopulmonary bypass (CPB) 
were shown to affect EVLW differently, with lower values of EVLW in patients 
undergoing CPB with colloid primes (106,107). However, most of these studies were 
unable to measure differences in pulmonary edema, associated with resuscitation 
with either colloids or crystalloids in cardiac surgery patients (20,85,89,90).  
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There is evidence in the literature that some fluids influence pulmonary injury and 
edema, independently from the COP, by virtue of ‘plugging the leaks’ (108,109). 
Another possible mechanism includes anti-oxidant effects of both albumin and 
starches (110-112) and inhibition of the activation of leukocytes and the endothelium, 
thereby inhibiting an increase in microvascular permeability (113-116). 
 
In conclusion, the best resuscitation fluid is unknown. There is no clear evidence 
from the literature that colloids are more effective than crystalloids in plasma volume 
expansion or in improving myocardial function, provided that enough volume is given. 
Furthermore, evidence is lacking that colloids are more favorable in inhibiting the 
genesis of pulmonary edema and improving pulmonary gas exchange. In clinical 
practice, the availability, costs and expertise generally determine the choice of the 
type of fluid given (80). 
 
OBJECTIVES AND OUTLINES 
 
In this part of the study, we aimed at clarifying the hemodynamic efficacy of different 
resuscitation fluids relative to the pulmonary side effects in critically ill patients at risk 
for ALI and ARDS. We included patients after cardiac or major vascular surgery with 
hypotension, defined as systolic blood pressure below 110 mm Hg, and 
hypovolemia, defined as reduced filling pressures (PCWP ≤ 10 mm Hg or CVP ≤ 8 
mm Hg). We compared filling pressure-guided infusion of the colloids gelatin 4%, 
hydroxyethyl starch 6% and albumin 5% with normal saline 0.9%, having roughly the 
same colloid osmotic pressure. 
 
In chapter 5, we studied the short-term hemodynamic effects of colloids compared 
to saline. We hypothesized that colloids are more effective in elevating intravascular 
volume by maintaining the COP, thereby increasing the preload of the heart and 
consequently cardiac output, as compared to crystalloids, which may rapidly 
disappear in the interstitium. We further hypothesized that exogenous colloids 
perform similarly to albumin in this respect. We evaluated changes in cardiac index 
together with plasma COP, plasma volume and cardiac performance, using a 
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standard pressure-guided fluid challenge protocol over 90 minutes (117). The 
function and loading of the heart were evaluated by calculating the left ventricular 
stroke work index (LVSWI) from stroke volume and mean arterial blood pressure; we 
measured the global end-diastolic volume of the heart (GEDV) together with the 
CVP. These measurements enabled us to calculate the myocardial compliance and 
contractility.   
 
In chapter 6, we examined the effects of colloids and crystalloids on pulmonary 
function by simultaneously measuring gas exchange, radiological abnormalities, the 
COP, EVLW, the lung injury score (10) and microvascular permeability. We 
hypothesized that in patients at risk for an increase in microvascular permeability, 
colloids are superior to saline in preventing pulmonary complications, resulting in less 
protein extravasation, less deterioration of the chest radiograph and ventilatory 
variables. We also hypothesized that albumin 5% and hydroxyethyl starch lower 
permeability-edema, independent of the COP, either by ‘plugging the leaks’ or 
possible anti-inflammatory effects.  
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ABSTRACT 
 
Background. Cardiac surgery can be complicated by pulmonary abnormalities, but it 
is unclear how various manifestations interrelate. 
Methods. A prospective study in the intensive care unit was done on 26 mechanically 
ventilated patients without cardiac failure, within three hours after elective cardiac 
surgery involving cardiopulmonary bypass. Edema (extravascular lung water, EVLW) 
was measured by the thermal-dye technique, permeability by a dual radionuclide 
technique yielding a pulmonary leak index (PLI), and radiographic, mechanical and gas 
exchange features were used to calculate the lung injury score (LIS), ranging between 
0 and 4. Evidence for left lower lobe atelectasis was obtained from plain radiographs. 
The plasma colloid osmotic pressure (COP) was measured by an oncometer. 
Results. The EVLW (normal <7 mL/kg) was elevated in 36% of patients and the PLI 
(normal <14.1 x 10-3/min) in 44%, but the variables did not directly interrelate. Patients 
with a supranormal EVLW had a lower COP than patients with normal EVLW. The 
duration of mechanical ventilation was prolonged in patients (20%) with EVLW >10 
mL/kg. There was no difference in EVLW and PLI in patients with a LIS <1 and >1 
(31% of patients). In patients with radiographic evidence for atelectasis (46%), the 
positive end-expiratory pressure and inspiratory O2 fraction to maintain oxygenation 
were higher than in those without. 
Conclusions. After cardiac surgery, mild pulmonary edema is relatively common, even 
in the absence of high filling pressures, and mainly attributable to a low COP, 
irrespective of increased permeability in about half of patients. It may prolong 
mechanical ventilation at EVLW >10 mL/kg. However, pulmonary radiographic and 
ventilator abnormalities may result, at least in part, from atelectasis rather than from 
increased permeability edema.  
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INTRODUCTION 
 
Cardiac surgery carries a variety of pulmonary complications, some of them 
contributing to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) 
(1,2). They may consist of increased pulmonary capillary protein permeability (3-5), 
increased extravascular lung water (EVLW) or edema (6-20) and atelectasis (15,21-
24), which, either alone or together, may contribute to radiographic, mechanical and 
gas exchange abnormalities, hypoxemia, temporary ventilator-dependency and 
ultimate morbidity and mortality, at least in some patients (25,26). Although risk factors 
for some of these changes have been identified (2,6,12,14), the prevalence of 
pulmonary complications widely varies between studies, when looking at the different 
manifestations. For instance, the increase in EVLW after surgery has been claimed to 
be minimal in some reports but substantial in others (6,7,10-13,19,20,23,26). As 
measured by non-invasive radionuclide techniques, pulmonary capillary protein 
permeability may increase in some patients, probably as a result of ischemia, 
reperfusion and a proinflammatory response (25,27), but not in others (3-5,28). 
Moreover, it is unclear if and how the ALI-ARDS criteria, i.e. radiographic, mechanical 
and oxygenation changes on the one hand and permeability and edema on the other, 
overlap or interrelate (3,4,6,7,13,15,24,25,26,29). For instance, (transient) lung edema 
after cardiac surgery can been caused by increased permeability (3-5), a low colloid 
osmotic pressure (6,8,12,18), or a high hydrostatic filtration pressure in the lungs 
(6,11,14), and may or may not affect the chest radiograph, lung mechanics and 
oxygenation (6,7,13,23,26). Indeed, a fall in oxygenation and lung compliance might be 
caused by atelectasis rather than by increased permeability and edema, as suggested 
by computer tomography (CT) scanning, even though alveolar collapse is hard to 
measure (3,4,7,15,18,21-24,30). Indeed, CT may only poorly differentiate between 
fluid, e.g. edema, and atelectasis (31). Differentiating is important since the latter more 
likely responds to recruitment maneuvers than the former (32). Taken together, the 
interrelationship between the various manifestations of pulmonary complications after 
cardiac surgery is unclear, and the role of increased permeability and edema in 
radiographic and ventilatory abnormalities can be doubted. 
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To evaluate the occurrence and causes of pulmonary edema and to assess its 
contribution, versus atelectasis, in lung radiographic, gas exchange and mechanical 
abnormalities, we studied 26 mechanically ventilated patients within three hours after 
cardiac surgery involving cardiopulmonary bypass without signs of cardiac failure, in 
whom EVLW, capillary permeability, gas exchange, radiographic and ventilatory 
parameters were measured simultaneously and independently in the intensive care 
unit (ICU).  
 
PATIENTS AND METHODS 
 
This is a prospective study, approved by the Ethical Committee of the Vrije Universiteit 
Medical Centre, involving 26 consecutive patients after elective cardiac surgery 
involving cardiopulmonary bypass. In this university hospital, about 750 open heart 
procedures are performed per year. Written informed consent was obtained pre-
operatively in eligible patients (n=52). The inclusion criteria were the presence of a 
pulmonary artery (n=24) or central venous catheter (n=2), postoperatively. Exclusion 
criteria were an age above 79 years and pregnancy (prior to surgery), a life expectancy 
less than 24 hours and signs of cardiac failure, defined by a cardiac index (CI) below 
2.0 L/min/m2 and a central venous pressure (CVP) above 13 or pulmonary capillary 
wedge pressure (PCWP) above 15 mm Hg, after surgery at arrival in the ICU (14). On 
the day of the surgery, anesthesia was induced with sufentanil, pancuronium and 
midazolam, and maintained with a continuous infusion of propofol. At induction, 50-100 
mg of dexamethasone was administered. Radial artery, central venous and pulmonary 
artery catheters were inserted for hemodynamic measurements and blood sampling. 
After tracheal intubation, the lungs were volume-controlled ventilated with a tidal 
volume (Vt) of 8-10 mL/kg resulting in an end-tidal CO2 concentration between 4 and 
5%, using an O2-air mixture with an inspiratory O2 fraction (FiO2) of 40% and a positive 
end-expiratory pressure (PEEP) of 5 cm H2O (I:E 1:2). The patients underwent 
cardiopulmonary bypass (CPB) during which the lungs were not ventilated. The 
extracorporeal circulation system was primed with 300 mL of Ringer's lactate, 1000 mL 
of gelatin 4%, 100 mL of 20% mannitol, 50 mL of 8.4% sodium bicarbonate, 200 mL of 
aprotinine and 5000 IU of heparin (33). After systemic heparinization (300 IU/kg), CPB 
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(Stockert-Sorin S3, Sorin Biomedica, Mirandola, Modena, Italy) was started, provided 
that the activated clotting time was more than 480 sec. Non-pulsatile flow rate was 
maintained at 2-3 L/min/m2, depending on the acid-base balance, pre-operative 
cardiac output and lactate concentrations. Patients were cooled to 32 °C 
nasopharyngeal temperature. Mean arterial pressure (MAP) was maintained at 50-80 
mm Hg during CPB and if the MAP declined to less than 50 mm Hg, the blood flow 
rate was increased, or vaso-active drugs were given. After aortic cross-clamping, all 
patients received crystalloid cardioplegia for myocardial protection (in total, ± 2000 mL, 
potassium 16 mmol/L, 4 °C). Patients were weaned from CPB using inotropic support, 
if necessary. After termination of CPB, heparin was neutralized using an equivalent 
dose of protamine sulphate 3 mg/kg. Autologous blood and residual volume from the 
extracorporeal circuit were infused as first-choice fluid administration. Guided by low 
systemic and filling pressures, NaCl 0.9%, gelatin or starches were infused 
additionally. If the hemoglobin concentration was less than 6 mmol/L, packed red blood 
cells concentrates were infused. At the end of surgery, a 4F introducing sheath (Arrow, 
Reading, USA) was inserted into the femoral artery, for use in the study protocol, in 
each patient. No ventilatory recruitment maneuvers were attempted. 
 
Table 1. Patient characteristics 
 
Age, year     61 (38-74) 
Sex, M/F     19 (73)/ 7 (27) 
Prior myocardial infarction   12 (46) 
Smoking history/COPD   5 (19) 
CPB time, min    112 (40-198) 
Type of surgery     
 CABG    17 (65) 
 AVR with or without CABG 7 (27) 
 ASD     2 (8) 
 LIMA     5 (19) 
APACHE II     9 (2-14) 
On vasoactive drugs 
 Dopamine    18 (69) 
 Nitroglycerin    22 (85) 
 
Median and ranges or number of patients (%), where appropriate. Abbreviations: COPD = chronic 
obstructive pulmonary disease; CPB = cardiopulmonary bypass; CABG = coronary artery bypass grafting; 
AVR = aortic valve replacement; ASD = atrial septal defect repair; LIMA = left internal mammary artery; 
APACHE = acute physiology and chronic health evaluation.  
 
EVLW was measured in 25 patients with help of the thermal-dye technique, after 
exclusion of one patient with catheter malposition (17). A 3F fiberoptic thermodilution 
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catheter was inserted in the femoral artery sheath. Fifteen mL of ice cold indocyanine 
green (ICG), 1 mg/mL D5W, was injected in a central vein and the thermal-dye dilution 
curve obtained at the femoral artery (COLD Z-021, Pulsion Medical Systems, Munich, 
Germany). This allowed calculation of the transpulmonary cardiac output, the 
intrathoracic blood volume (ITBV), the pulmonary blood volume (PBV) and the 
extravascular thermal volume in the lungs as a measure of EVLW (normal <7 mL/kg) 
(13,17). EVLW is typically two to three-fold elevated in case of overt (radiographic) 
pulmonary edema (17,29). The normal ratio of EVLW/ITBV (mL/mL) is 0.2 to 0.3 and 
the normal EVLW/PBV ratio is about 1, and the indices have been proposed to reflect 
permeability (19,29,34). Measurements were done in duplicate and averaged. The 
cardiac output was indexed to body surface area (cardiac index, CI).  
PLI was measured in 25 patients (4,28). Logistics precluded a measurement in one 
patient. In brief, autologous red blood cells were labeled with 99mTc (11 MBq, physical 
half-life 6h; Mallinckrodt Diagnostica, Petten, The Netherlands). Transferrin was 
labeled in vivo, following i.v. injection of 67Ga-citrate, 4.5 MBq (physical half-life 78 h; 
Mallinckrodt Diagnostica, Petten, The Netherlands). Patients were in the supine 
position and two scintillation detection probes (Eurorad C.T.T., Strasburg, France) 
were positioned over the right and left lung apices. Starting at the time of injection of 
67Ga, radioactivity was detected every minute, during 30 minutes. The count rates were 
corrected for background radioactivity, physical half-life and spill-over and expressed 
as counts per minute (CPM) per lung field. Until 30 minutes after 67Ga injection, blood 
samples (2 mL aliquots) were taken. Each blood sample was weighed and radioactivity 
was determined with a single well well-counter, corrected for background, spillover and 
decay (LKB Wallac 1480 WIZARD, Perkin Elmer, Life Science, Zaventem, Belgium). 
Results were expressed as CPM/g. For each blood sample, a time-matched CPM over 
each lung was taken. A radioactivity ratio was calculated, (67Galung/99mTclung)/ 
(67Gablood/99mTcblood), and plotted against time. The PLI was calculated, using linear 
regression analysis, from the slope of increase of the radioactivity ratio divided by the 
intercept. The PLI represents the transport rate of 67Ga from the intravascular to the 
extravascular space of the lungs and is therefore a measure of pulmonary vascular 
permeability (4,28). The values for both lung fields were averaged. The upper limit of 
normal for the PLI is 14.1 x 10-3/min and the measurement error is about 10% (4,28). 
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The PLI is typically elevated more than three- to fourfold in ARDS (4,28). 
Radiography and lung injury score (LIS). The latter was calculated from the number 
of quadrants on the chest radiograph with opacities, the PEEP level, the arterial PO2 
(PaO2)/inspiratory O2 fraction (FiO2) and the dynamic total respiratory compliance (35). 
The compliance was calculated from tidal volume/(plateau pressure-PEEP), mL/cm 
H2O. The chest radiograph was scored by a consultant radiologist, blinded to the 
study, who evaluated the number of quadrants with alveolar opacities, ranging from 0 
to 4. In addition, the presence of blurring of the left hemidiaphragm and costophrenic 
angle by alveolar opacification was recorded as radiographic evidence for left lower 
lobe atelectasis. The LIS ranges between 0 (no injury) to 4, with values above 2.5 
indicative of ARDS, and between 0 and 2.5 of ALI (35). 
Protocol. After surgery, the patients were admitted to the ICU. The patients were 
connected to the ventilator (Evita 4, Dräger, Lübeck, Germany) and volume-controlled 
ventilation was started with similar settings as during surgery. Demographics were 
recorded, including the acute physiology and chronic health evaluation (APACHE-II) 
score, measurements of EVLW, 67Ga-transferrin PLI and hemodynamics were 
performed, and an anteroposterior chest radiograph was made. Hemodynamic 
variables were measured after calibration and zeroing to atmospheric pressure at mid-
chest level (TramscopeR, Marquette, Wisc., USA). Mean pulmonary artery pressure 
(MPAP), CVP and, after balloon inflation, the PCWP were taken at end-expiration, with 
patients in the supine position, if adequate tracings for the latter could be obtained 
(n=17). Arterial blood samples were obtained for determinations of partial O2/CO2 
pressures and O2 saturations (Rapidlab 865, Bayer Diagnostics, Tarrytown, NY, USA, 
at 37 °C), hemoglobin, albumin and total protein levels (Roche/Hitachi 747, Roche 
Diagnostics Corporation, Indianapolis, IN, USA). Mixed (n=24) or central (n=2) venous 
blood was taken simultaneously for measurement of partial pressures and saturations. 
Shunt fraction (Qs/Qt) was calculated according to standard formulae. The plasma 
colloid osmotic pressure (COP) was measured by a membrane osmometer (Osmomat 
050, Gonotex, Berlin, Germany, molecular cut-off at 20 kDa, normal about 24 mm Hg). 
The FiO2, tidal volume, plateau inspiratory pressure and PEEP (cm H2O) were taken 
from the ventilator. Doses of vasoactive drugs were recorded. Patients were taken care 
of by intensive care physicians not involved in the study and followed until extubation 
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and discharge/death in the ICU. The duration of mechanical ventilation was defined as 
the interval from admission to extubation. 
 
 
Table 2. Post cardiac surgery patients with and without pulmonary edema or increased 
permeability 
 
    EVLW <7 ml/kg EVLW >7 ml/kg PLI <0.0014/min PLI >0.0014/min 
    n=16   n=9   n=14   n=11 
 
Hemodynamics 
MAP, mm Hg  74 (52-104)  80 (66-102)  72 (52-102)  84 (63-104)4 
CVP, mm Hg  5 (0-7)  6 (2-12)  6 (0-12)  4 (0-7) 
PCWP, mm Hg  n=10   n=6   n=10   n=6 
    8 (1-11)  9 (4-13)  8 (3-13)  7 (1-10) 
MPAP, mm Hg   14 (8-22)  18 (12-23)  18 (9-23)  13 (8-21) 
CI, L/min/m2   3.1 (2.4-4.3)  2.6 (2.2-3.5)3 3.2 (2.2-4.3)  2.7 (2.3-3.8) 
COP, mm Hg  19 (18-22)  18 (15-20)1  19 (15-21)  19 (15-22) 
 
Pulmonary changes 
PLI, x 10-3/min  n=16   n=8   n=14   n=11 
    18 (8-60)  13 (6-24)4  11 (6-15)  24 (19-60)7 
Supranormal PLI  8 (50)   2 (25)   na   na   
EVLW, mL/kg  n=16   n=9   n=14   n=10 
    5.3 (2.1-6.7)  10.3 (7.1-20.0)7 6.3 (3.7-20.0) 5.6 (2.1-8.3) 
Supranormal EVLW na   na   6 (43)   2 (20) 
EVLW/ITBV   0.19 (0.08-0.47) 0.43 (0.26-0.63)7 0.29 (0.13-0.63) 0.19 (0.08-0.48) 
EVLW/PBV   1.0 (0.3-2.9)  3.5 (1.2-8.7)7  1.5 (0.6-8.7)  0.9 (0.3-4.4) 
PaO2, mm Hg  114 (92-174)  119 (84-189)  108 (84-185)  155 (92-184) 
FiO2, %   41 (39-61)  40 (39-62)  43 (39-62)  40 (39-51) 
PaO2/FiO2   263 (164-435) 290 (140-485) 244 (140-463) 355 (202-472)2 
Qs/Qt, %   15 (10-28)  13 (6-62)  18 (9-62)  14 (10-28) 
PEEP, cm H2O  7 (5-16)  8 (5-15)  7 (5-16)  6 (5-8)5 
Pplat, cm H2O  16 (14-33)  18 (13-28)  17 (13-33)  18 (14-22)  
Vt, mL    547 (395-1110) 550 (500-670) 535 (459-1110) 550 (395-670) 
Compliance, mL/cm H2O 51 (38-80)  50 (39-83)  59 (38-83)  48 (38-69)5 
Radiographic quadrants 0 (0-2)  0 (0-3)  0 (0-3)  0 (0-2) 
Atelectasis   10 (63)  2 (22)6  9 (64)   3 (27) 
LIS    1.0 (0.2-1.7)  0.7 (0.5-2.7)  1.0 (0.5-2.7)  0.7 (0.2-1.2) 
Duration mechanical ventilation, h  
    11 (5-19)  11 (5-494)  12 (5-494)  10 (5-15) 
 
Median (ranges or %, where appropriate); Abbreviations: MAP = mean arterial pressure; CVP = central 
venous pressure; PCWP = pulmonary capillary wedge pressure; MPAP = mean pulmonary arterial 
pressure; CI = cardiac index; COP = colloid osmotic pressure; PLI = pulmonary leak index; EVLW = 
extravascular lung water; ITBV = intrathoracic blood volume; PBV = pulmonary blood volume; a = arterial; 
FiO2 = inspiratory O2 fraction; Qs/Qt = shunt fraction; PEEP = positive end-expiratory pressure; Pplat = 
plateau pressure; Vt = tidal volume; LIS = lung injury score; na = not applicable. P (exact if <0.10): 
1P=0.02, 2P=0.05, 3P=0.06, 4P=0.07, 5P=0.09, 6P=0.10, 7P=na 
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Statistical analysis. We dichotomized groups with normal and elevated (>7 mL/kg) 
EVLW, normal and elevated (>14.1 x 10-3/min) PLI and a LIS below and above 1. Data 
were summarized as median and range and groups were compared with help of the 
non-parametric Mann-Whitney U test for unpaired data. Fisher's exact test was used to 
compare frequencies. The Spearman correlation coefficient was used to express 
relations. Exact P values below 0.10 are given. 
 
RESULTS 
 
The postoperative course was uneventful in all but one patient, in spite of relatively low 
oxygenation ratios and dynamic compliances shortly after surgery. The patients 
(except for one) were transferred from the ICU to special postcardiac surgery wards on 
the day after surgery. One patient died 9 days after admission following pulmonary 
hemorrhage. Table 1 includes some details on patient characteristics. There were no 
differences in vasoactive support or in PaCO2 among subgroups. 
Pulmonary edema (EVLW >7 mL/kg, Table 2). The EVLW was mildly elevated in 
36% of patients, independently of ITBV or PBV, and COP was lower in patients with an 
elevated EVLW. Compared with patients with a normal EVLW, those with an elevated 
EVLW had a lower COP-CVP gradient, i.e. 14 (12-21) in the former and 12 (6-15) mm 
Hg in the latter (P=0.009). The EVLW, EVLW/ITBV and EVLW/PBV inversely 
correlated to the COP-CVP (minimum rs=-0.49, P=0.016, Figure 1), while the relations 
to either COP or CVP alone were weaker. The COP inversely correlated to CPB time 
(rs=-0.51, P=0.009). Five patients (20%) had an EVLW of 10 mL/kg or higher and their 
duration of mechanical ventilation was longer (P=0.042) than in patients with EVLW 
<10 mL/kg. EVLW did not relate to LIS nor its components.  
Increased permeability (PLI >14.1 x 10-3/min, Table 2). An elevated PLI was present 
in 44% of patients. There were no differences in study variables between patients with 
normal and elevated PLI, except for a higher oxygenation ratio in the latter. The PLI 
weakly and inversely related to the EVLW, EVLW/PBV and EVLW/ITBV (minimum rs= 
-0.42, P=0.042) and to PEEP and dynamic compliance (minimum rs=-0.40, P=0.049).  
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Atelectasis. Table 3 describes patients with or without radiographic evidence for left 
lower lobe atelectasis. The presence of atelectasis coincided with a higher PEEP and 
FiO2 necessary to maintain oxygenation than the absence of atelectasis. There was no 
difference in compliance between patients with or without evidence for atelectasis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIS (Table 3). There was one patient with a LIS >2.5 and 3 quadrants of alveolar 
opacities on chest radiography. This patient had a PLI of 14.0 x 10-3/min, an EVLW of 
13 mL/kg, a COP of 18 mm Hg, PCWP of 13 mm Hg and evidence for atelectasis. 
Otherwise, patients with a low (<1) or high (>1, 31%) LIS did not differ in EVLW nor in 
PLI, but in the clinical variables composing the LIS, which were more severely affected 
in the high LIS group. In addition, cardiac filling pressures (and MPAP) were higher in 
patients with high LIS and relatively high PEEP than in those with low values. Indeed, 
the MPAP, PCWP and CVP related to PEEP (minimum rs=0.51, P=0.01). The LIS 
directly related to Qs/Qt (rs=0.46, P=0.01), the latter tending to differ between LIS 
groups.  
 
Figure 1. Inverse relation between extravascular lung water (EVLW, n <7 mL/kg) and 
pressure gradient between plasma colloid osmotic (COP) and central venous pressure 
(CVP) in 26 patients after cardiac surgery: rs=-0.58, P=0.003 
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Table 3. Patients without or with lung injury or radiographic evidence for left lower lobe 
atelectasis 
 
    No atelectasis With atelectasis LIS <1  LIS >1 
    n=14   n=12   n=18   n=8 
 
Hemodynamics 
MAP, mm Hg  82 (63-102)  73 (52-104)  79 (58-104)  71 (52-102) 
CVP, mm Hg  4 (0-7)  5 (0-12)  4 (0-6)  7 (5-12)1 
PCWP, mm Hg  n=9   n=8   n=11   n=6 
    7 (3-10)  9 (1-13)5  7 (1-11)  9 (7-13) 
MPAP, mm Hg  14 (10-22)  17 (8-23)  14 (8-21)  18 (13-23)3 
CI, L/min/m2   2.8 (2.2-3.8)  3.1 (2.5-4.3)  2.7 (2.2-4.3)  3.2 (2.6-3.5) 
COP, mm Hg  19.3 (14.6-20.7) 18.9 (17.8-21.7) 18.7 (14.6-21.7) 19.0 (17.8-20.8) 
 
Pulmonary changes 
PLI, x10-3/min  n=13   n=12   n=17   n=8 
    20 (6-60)  13 (8-53)  19 (8-60)  14 (6-30)  
Supranormal PLI  8 (62)   3 (25)   9 (53)   2 (25)  
EVLW, mL/kg  n=13   n=12   n=17   n=8 
    7.1 (2.1-20.0) 5.3 (2.9-13.2) 5.4 (2.1-20.0) 6.4 (5.2-13.2) 
Supranormal EVLW 7 (54)   2 (17)7  6 (35)   3 (38) 
EVLW/ITBV, mL/mL 0.26 (0.08-0.63) 0.27 (0.13-0.47) 0.25 (0.08-0.63) 0.28 (0.18-0.47) 
EVLW/PBV, mL/mL 1.26 (0.27-8.75) 1.42 (0.59-4.03) 1.4 (0.3-8.7)  1.3 (0.8-4.0) 
PaO2, mm Hg  125 (84-189)  121 (93-173)  143 (84-189)  106 (87-174) 
FiO2    40 (39-62)  43 (39-61)4  40 (39-51)  50 (40-62)2 
PaO2/FiO2   316 (140-485) 263 (164-422) 349 (202-485) 227 (140-435)8 
Qs/Qt, %   13 (5-29)  17 (14-62)7  14 (5-29)  18 (12-62)6 
PEEP, cm H2O  5 (5-10)  7 (5-16)3  5 (5-9)  10 (7-16)8 
Pplat, cm H2O  17 (13-22)  18 (14-33)  17 (13-22)  17 (15-33) 
Vt, mL    550 (395-670) 550 (420-1110) 560 (420-670) 510 (395-1110) 
Compliance, mL/cm H2O 50 (39-83)  51 (38-80)  50 (38-80)  53 (39-83)8 
Radiographic quadrants 0 (0-2)  0 (0-3)  0 (0-1)  1 (0-3)8 
Atelectasis   na   na   7 (39)   5 (63)   
LIS    0.7 (0.2-1.2)  1.0 (0.5-2.7)  0.7 (0.2-1.0)  1.4 (1.2-2.7)8 
Duration mechanical ventilation, h  
    11 (5-316)  11 (8-494)  12 (5-316)  11 (6-494) 
 
Median (ranges or %, where appropriate); N = number of patients. Abbreviations: MAP = mean arterial 
pressure; CVP = central venous pressure; PCWP = pulmonary artery occlusion pressure; MPAP = mean 
pulmonary artery pressure; CI = cardiac index; COP = colloid osmotic pressure; PLI = pulmonary leak 
index; EVLW = extravascular lung water; ITBV = intrathoracic blood volume; PBV = pulmonary blood 
volume; a = arterial; FiO2 = inspiratory O2 fraction; Qs/Qt = shunt fraction; PEEP = positive end-expiratory 
pressure; Pplat = plateau pressure; Vt = tidal volume; LIS = lung injury score; na = not applicable. P (exact if 
< 0.10): 1P=0.000, 2P=0.01, 3P=0.04, 4P=0.05, 5P=0.07, 6P=0.08, 7P=0.10, 8P=na  
 
 
DISCUSSION 
 
Our study, employing simultaneous and independent measures of edema, 
permeability, radiography, mechanics and gas exchange in the lungs, suggests that 
these indicators do not well interrelate, in patients after cardiopulmonary bypass 
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surgery without overt cardiac failure. In contrast, it suggests that edema is caused by a 
low COP rather than increased permeability and that atelectasis better explains the 
pulmonary radiographic abnormalities and need for PEEP and FiO2 to maintain 
oxygenation than increased permeability pulmonary edema. Hence, our findings may 
have therapeutic implications, since atelectasis would be treated by altering ventilatory 
settings and opening the lungs, rather than with help of diuretics to attenuate edema 
(32). Even though we did not actively attempt to recruit the lungs of patients, most of 
them had an uneventful recovery, except for a relatively prolonged duration of 
mechanical ventilation in patients with moderate to severe pulmonary edema. 
 
The frequency of EVLW elevations in our patients agrees with the literature, 
documenting slight and transient rises in EVLW and pulmonary edema after cardiac 
surgery, even though the causes and consequences remained unclear (6,8-
10,12,14,15). In other studies, however, the EVLW was normal (7,11,13,19,20,23,26). 
Boldt et al. (9) described that accumulation of EVLW particularly occurred in elderly 
(>70 years of age) and not in younger patients after cardiac surgery and Buhre et al. 
(16) described pronounced elevations of EVLW after mitral valvular as opposed to 
coronary artery surgery. These patient-bound factors did not appear to predispose to 
pulmonary edema in our study, however, partly because we excluded patients 
undergoing mitral valve replacement and with overt cardiac failure. 
 
Our data suggest that, after cardiac surgery, a low COP, independently of hydrostatic 
pressure factors and permeability, contributes to an elevated EVLW, as suggested 
before on the basis of a calculated rather than measured COP (6,8). Apparently, 
increased permeability, i.e. an elevated PLI, contributed less to a rise in EVLW than a 
low COP, thus arguing against a predominant role of a pro-inflammatory response to 
bypass surgery to edema formation in the lungs (19,25,27). Indeed, even in ALI 
evoked by oleic acid in dogs, increased permeability may only partially explain 
pulmonary edema (36). Conversely, hypoproteinemia has been associated with ARDS 
(37) and acute diastolic heart failure (38), so that a low COP may contribute to 
pulmonary edema of both cardiogenic and non-cardiogenic origins. As for the PLI (28), 
the reproducibility of EVLW measurements may be within 10% (17), so that 
measurement errors cannot account for the lack of a direct correlation between PLI 
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and EVLW, thereby offering no explanation for the inverse relation either, unless 
reflecting two populations, one with elevated EVLW and normal PLI and the other with 
normal EVLW and elevated PLI. The EVLW as a measure of pulmonary edema may 
be confounded by areas with edema that are underperfused, thereby escaping 
detection by the thermal-dye technique and perhaps contributing to the inverse relation 
between EVLW and PLI (10,29). However, CI did not relate to EVLW or to PLI in our 
study, so that the CI cannot be the source of the inverse relation between EVLW and 
PLI. Perfusion-dependent EVLW may also mainly apply to direct forms of lung injury, 
rather than indirect forms (29,36), as in the current study. Boldt et al. (10) 
demonstrated that the EVLW measurement is independent of CI, after cardiac surgery. 
A final limitation of our study is that the PLI, EVLW and atelectasis are assessed at 
differing places in the lung in a relatively small number of patients, and that the PLI 
may be subject to sampling error, even though an inflammatory increase of 
permeability might be expected to be homogeneous. A potential perfusion limitation of 
EVLW and PLI in atelectatic areas may, otherwise, also explain the tendency for lower 
oxygenation and higher frequency of atelectasis in patients with low EVLW or low PLI. 
Although a CT scan could overcome some of the limitations mentioned, direct and 
independent measurements of edema, permeability and atelectasis, as done in this 
study, cannot be performed by CT (30,31). 
 
The fall in plasma COP after cardiac surgery is partly determined by priming of the 
cardiopulmonary bypass and administration of non-protein colloids during surgery 
(26,33). Lumb (11) suggested that priming the system with albumin or hydroxyethyl 
starch ameliorated a postoperative increase in EVLW. Hoeft et al. (12) observed that 
EVLW increased in patients on bypass primed with Ringer's lactate but not if primed 
with albumin solution, but were not able to reproduce these findings in patients 
undergoing mitral valve replacement (16). Eising et al. (18) used a hyperoncotic (10%) 
hydroxyethyl starch solution to prime the cardiopulmonary bypass circuit and found 
less accumulation of EVLW after surgery than when the circuit had been primed by 
saline. We used gelatin solution to partially prime the circuit (26,33) and this may have 
been insufficient to prevent a fall in COP and rise in EVLW in some patients. 
Otherwise, the EVLW/PBV and EVLW/ITBV have been advocated as measures of 
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pulmonary permeability (19,29,34). Our results indicate that the ratio of EVLW to blood 
volumes may also rise upon a fall in COP. Finally, a supranormal EVLW did not 
correlate with alveolar opacities on chest radiography, increased shunt fraction or a low 
oxygenation ratio, and, indeed, a poor correlation between (changes in) radiographic 
opacities, gas exchange and EVLW has been observed previously, unless patients 
with overt cardiac failure are included (11,13,26,29,39). Indeed, considerable lung 
edema (EVLW >10 mL/kg) must develop before becoming evident on the chest 
radiograph and impairing gas exchange (6,7,11,13-15,18,39). 
 
That the CVP better predicted EVLW than the PCWP, in conjunction with the COP, 
may relate to the small numbers of the latter or greater importance of the former. 
Indeed, systemic venous pressure is the back pressure for lymphatic flow from the 
lungs, so that an elevated pressure contributes to pulmonary edema, evoked by 
increased permeability, increased hydrostatic pressures, or both (40). The COP-
PCWP gradient has been proposed as the intravascular filtration pressure linked to 
development of pulmonary edema, even though the level of the effective hydrostatic 
filtration pressure is somewhere between the MPAP and the PCWP and may be 
relatively independent of PCWP (6,8,11,12,26,34,38). Our data suggest the COP and 
CVP as the main determinants of edema in cardiac surgical patients, and the gradient 
incorporates measures of intravascular filling, filtration and outflow pressure for 
pulmonary edema. In any case, the lower cardiac filling pressures in the LIS <1 than 
LIS >1 group could be largely explained by differences in PEEP.  
 
The ARDS prevalence after cardiac surgery in our study conforms with that reported in 
the literature, between 0.5 and 2.5% (1,2). Since the EVLW was doubled, the PLI was 
normal in the patient meeting LIS criteria for ARDS (35) and the PLI is uniformly 
elevated in ARDS (4,28), we cannot exclude that the patient suffered from 
overhydration rather than ARDS. Conversely, our data suggest that in moderately 
severe forms of lung injury after cardiac surgery, in which an elevated PLI can be 
demonstrated, the increased permeability that is believed to result from the injury 
following bypass-associated ischemia, reperfusion and a proinflammatory response (3-
5,19,25,27), does not translate into greater edema formation and lower oxygenation 
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than in patients with normal postoperative permeability, even though the prevalence of 
an elevated PLI after cardiac surgery agrees with previous studies (3-5).  
 
Our data may imply that radiographic, mechanical and gas exchange abnormalities, 
expressed in the LIS (35), are not, wholly or in part, the result of pulmonary 
permeability or edema. In contrast, we can largely attribute the radiographic and gas 
exchange abnormalities to postoperative atelectasis, particularly common in the left 
lower lung lobe, as judged from the predominant location of opacities on the 
postoperative chest radiograph, and leading to alveolar collapse, a fall in lung volume 
and increased shunt fraction (30). This may confirm and extent studies by other 
investigators, reporting that CT scanning of patients 20 h post cardiac surgery revealed 
basal opacities suggestive for atelectasis in the absence of edema, thereby increasing 
the shunt fraction (21). Lung collapse during cardiopulmonary bypass may have 
contributed in our patients. Moreover, the low postoperative compliance agrees with 
the literature but did not relate to edema, in agreement with some but not with other 
authors, even though the fall in compliance after cardiac surgery is at least as great for 
the lungs as for the chest wall (15,22-24). The inverse association between PLI on the 
one hand and PEEP and compliance on the other can be explained by an underlying 
inflammatory response (25,27). The cause of a low compliance remains otherwise 
unclear and cannot be directly attributed to atelectasis either, suggesting a major 
influence by surgery and anesthesia (15,21-24,30). Finally, our data do not suggest 
that edema contributed to atelectasis by gravitational forces, with a tendency for lower 
EVLW in patients with than without atelectasis. 
 
In conclusion, mild pulmonary edema is relatively common shortly after 
cardiopulmonary bypass surgery, even in the absence of cardiac failure, and is mainly 
attributable to a low COP, irrespective of increased permeability in about half of 
patients. It may prolong mechanical ventilation if >10 mL/kg. However, the pulmonary 
radiographic, gas exchange and mechanical abnormalities are poor indicators of 
increased pulmonary permeability and edema, so that the former may be largely 
attributable to atelectasis. 
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ABSTRACT 
 
Questions of the study. To reveal the pathogenesis of pulmonary ventilatory and 
radiographic abnormalities in patients after major vascular surgery.  
Patients and methods. Sixteen mechanically ventilated patients without heart failure 
were studied, within three hours after major vascular surgery. We measured 
extravascular lung water (EVLW), intrathoracic (ITBV), global end-diastolic (GEDV) 
and pulmonary (PBV) blood volumes, 67Ga-transferrin pulmonary leak index (PLI), and 
ventilatory and radiographic variables. The latter allowed computation of the lung injury 
score (LIS) as a measure of lung injury. 
Results. The EVLW was elevated (>7 mL/kg) in 5/16 (31%) of patients, while the PLI 
was elevated in 11/16 (69%) and a supranormal EVLW was associated with a high PLI 
and higher EVLW relative to ITBV or PBV. Patients arbitrarily divided into those with a 
>1 and ≤1 LIS differed in the factors composing the score as well as in EVLW divided 
by PBV. A LIS >1 was associated with a longer duration of mechanical ventilation. 
Answer to the question. Our data suggest that mild, subclinical, pulmonary edema is 
relatively common after major vascular surgery, and mainly caused by increased 
pulmonary capillary permeability, in the absence of overt heart failure. However, 
permeability edema only partially contributes to postoperative LIS and need for 
mechanical ventilation, suggesting a major contribution by atelectasis. 
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INTRODUCTION 
 
Complications of major vascular surgery include lung gas exchange and mechanical 
disturbances, and the need for prolonged mechanical ventilation after surgery (1-7). 
There is ample experimental evidence to suggest that lower body or gut 
ischemia/reperfusion (I/R) releases a wide variety of humoral and cellular mediators 
contributing to lung vascular damage (5,8). In humans, we demonstrated before that 
the permeability to intravenously injected and 67Ga- or 111In-labeled transferrin is 
increased in the lungs directly but not remotely after aortic surgery, as compared to 
preoperative values and probably associated with a proinflammatory response 
originating from the I/R area and affecting the lungs (7,9,10). This was accompanied 
by subtle lung gas exchange, mechanical and radiographic abnormalities, but a 
relation of the latter phenomena with release of inflammatory mediators and increased 
permeability could not be established (9,10). Nevertheless, increased permeability 
might contribute to a postoperative elevation of EVLW observed in some patients, 
since pulmonary fluid accumulation may only partially relate to a high hydrostatic 
and/or low colloid osmotic pressures (1,2,11). However, lung gas exchange, 
mechanical and radiographic variables may only partially relate to EVLW in critically ill 
patients (4,12,13). A postoperative increase in elastance or a decrease in compliance 
may thus relate to postoperative pulmonary vascular congestion or atelectasis rather 
than edema (4,6,14). Insight into the pathogenesis and interrelations of pulmonary 
abnormalities after major vascular surgery and I/R could help in designing preventive 
or therapeutic measures beyond the current practise to mechanically ventilate patients 
until gas exchange has recovered and extubation can be carried out (4,6).  
 
The current study was thus performed to elucidate the mechanisms of pulmonary 
ventilatory and radiographic abnormalities in relation to edema and increased 
capillary permeability, in patients after major vascular surgery and I/R, in the 
absence of heart failure. 
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PATIENTS AND METHODS 
 
This study is a single-center observational study. The study was approved by the 
Ethical Committee of the Vrije Universiteit Medical Center. Written informed consent 
was obtained in each of the 16 study patients, before planned laparotomy for major 
vascular surgery. The inclusion criteria, judged when the patients arrived at the 
intensive care unit (ICU), were absence of heart failure, defined as a pulmonary 
capillary wedge pressure (PCWP) at or below 15 mm Hg in the presence of a 
pulmonary artery catheter (n=3) or a central venous pressure (CVP) at or below 12 mm 
Hg in the presence of a central venous catheter, and a (transpulmonary) cardiac index 
greater than 2.0 L/min/m2. Patients were thus only included if they had arterial and 
pulmonary artery/central venous catheters. Exclusion criteria were: age >79 years, 
pregnancy, and a life expectancy of less than 24 hours. On the day of the surgery, 
anesthesia was induced with sufentanil 3 µg/kg i.v., pancuronium 0.1 mg/kg i.v. and 
midazolam 0.1 mg/kg i.v., and maintained with a continuous infusion of propofol. 
Radial artery, central venous or pulmonary artery catheters (n=3) were inserted for 
hemodynamic measurements and blood sampling. After tracheal intubation, the lungs 
were ventilated with a tidal volume of 8 mL/kg resulting in an end-tidal CO2 
concentration between 4 and 5% using an O2-air mixture with an inspiratory O2 
concentration of minimum 40%, depending on arterial PO2. A positive end-expiratory 
pressure (PEEP) of 5 cm H2O was applied, without recruitment maneuvers. Crystalloid 
and colloid fluids were infused, when necessary in the presence of low systemic and 
filling pressures. If volume therapy did not suffice, vasoactive drugs were given. In the 
presence of a hemoglobin concentration less than 6 mmol/L, packed red blood cells 
were infused. Preoperative use of aspirin and excessive bleeding prompted for 
administration of donor platelet concentrates. At the end of surgery, a 4F introducing 
sheath (Arrow, Reading, USA) was inserted into the femoral artery, when feasible, for 
use in the study protocol. The aortic clamping time was recorded. 
Study protocol. At the arrival of the patient in the ICU, the patient was connected to 
the ventilator (Evita 3, Dräger, Lübeck, Germany) and volume-controlled ventilation 
was started with similar settings as during surgery. The study protocol was started 
within three hours after arrival. Demographics were recorded, including the acute 
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physiology and chronic health evaluation (APACHE-II) score and baseline (t=0 min) 
measurements of hemodynamics were performed. Pressures were measured after 
calibration and zeroing to atmospheric pressure at midchest level (TramscopeR, 
Marquette, Wisc., USA). Mean pulmonary artery pressure, CVP and, after balloon 
inflation, the PCWP were taken at end-expiration, with patients in the supine position. 
The colloid osmotic pressure (COP) was measured by a membrane osmometer 
(Osmomat 050, Gonotex, Berlin, Germany, molecular cut-off at 20 kDa), in arterial 
blood samples. Arterial and mixed (n=3) or central venous (n=13) samples were taken 
for determination of PO2 and O2 saturation, for calculation of the oxygenation ratio 
(arterial PO2 [PaO2] over inspiratory O2 fraction [FiO2]) and shunt fraction Qs/Qt 
(Rapidlab 865, Bayer Diagnostics, Tarrytown, NY, USA), according to standard 
formulae. The FiO2, tidal volume, plateau inspiratory pressure and positive end-
expiratory pressure (PEEP, cm H2O) were taken from the ventilator. A chest 
radiograph was taken. Doses of vasoactive drugs were recorded. 
Transpulmonary thermal-dye dilution. The measurement involves a central venous 
injection of 15 mL of ice-cold indocyanine green (ICG), 1 mg/mL D5W. The thermal-
dye dilution curve was obtained at the femoral artery (COLD Z-021, Pulsion Medical 
Systems, Munich, Germany), with help of a 3F catheter (PV 2024, Pulsion Medical 
Systems, Munich, Germany), introduced via the introducing sheath. This allowed 
calculation of the transpulmonary thermodilution cardiac output and both the thermal 
as well as the ICG distribution volume, the intrathoracic blood volume (ITBV). The 
difference between the volumes is the extravascular thermal volume in the lungs as an 
estimate of extravascular lung water (EVLW, normal <7 mL/kg), as described and 
validated before (13,15,16). The pulmonary blood volume (PBV) is derived from 
cardiac output and the downslope time of the ICG dilution, as described before (15). 
The global end-diastolic volume (GEDV) is derived from intrathoracic thermal volume 
minus pulmonary thermal volume, the latter derived from the downslope time of 
thermal dilution. The normal ratio of EVLW/ITBV (mL/mL) is 0.2 to 0.3 and the normal 
EVLW/PBV ratio is about 1. The indices have been proposed to reflect permeability 
(15,17). Measurements were done in duplicate, irrespective of the ventilatory cycle, 
and averaged. GEDV and cardiac output were indexed to body surface area calculated 
from weight and height, while EVLW was indexed to body weight. 
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PLI. The PLI was measured according to previously described methods (9,10). In brief, 
autologous red blood cells were labeled with 99mTc (11 MBq, physical half-life 6h; 
Mallinckrodt Diagnostica, Petten, The Netherlands), using a modified in vitro method, 
to correct for blood volume under the probe. Ten minutes after administration of 
pyrophosphate (TechneScan, Mallinckrodt Medical, Petten, The Netherlands), 10 mL 
of blood was obtained and equilibrated with 99mTc. Ten minutes later the blood was 
reinjected. Transferrin was labeled in vivo, following i.v. injection of 67Ga-citrate, 4.5 
MBq (physical half-life 78 h; Mallinckrodt Diagnostica, Petten, The Netherlands). 
Patients were in the supine position and two cesium-iodide scintillation detection 
probes (Eurorad C.T.T., Strasburg, France) were positioned over the right and left lung 
apices. Starting at the time of injection of 67Ga, radioactivity was detected every 
minute, during 30 minutes. The count rates were corrected for background 
radioactivity, physical half-life and spill-over, and expressed as counts per minute 
(CPM) per lung field. Until 30 minutes after 67Ga injection, blood samples (2 mL 
aliquots) were taken. Each blood sample was weighed and radioactivity was 
determined with a single well well-counter, corrected for background, spillover, and 
decay (LKB Wallac 1480 Wizard, Perkin Elmer, Life Science, Zaventem, Belgium). 
Results were expressed as CPM/g. For each blood sample, a time-matched CPM over 
each lung was taken. A radioactivity ratio was calculated, (67Galung/99mTclung)/ 
(67Gablood/99mTcblood), and plotted against time. The PLI was calculated, using linear 
regression analysis, from the slope of increase of the radioactivity ratio divided by the 
intercept, to correct for physical factors in radioactivity detection. By taking pulmonary 
blood volume and thus presumably surface area into account, the radioactivity ratio 
represents the ratio of extravascular versus intravascular 67Ga radioacitivity. The PLI 
represents the transport rate of 67Ga from the intravascular to the extravascular space 
of the lungs and is therefore a measure of pulmonary capillary permeability (9,10). The 
values for both lungs were averaged. The upper limit of normal for the PLI is 14.1 x 10-
3/min and the measurement error is about 10% (9). The value is typically elevated 
three- to fourfold in case of acute respiratory distress syndrome (9). 
Radiography and the lung injury score. The lung injury score (LIS) was calculated 
from the number of quadrants on the chest radiograph with densities, the PEEP level, 
the PaO2/FiO2 and the dynamic total respiratory compliance (18). The latter was 
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calculated from tidal volume/(plateau pressure-PEEP), mL/cm H2O. The chest 
radiograph was scored by a consultant radiologist, blinded to the study, who evaluated 
the number of quadrants with alveolar densities, ranging from 1 to 4. The LIS ranges 
between 0 (no injury) to 4, with a value above 2.5 indicative of ARDS and between 0 
and 2.5 of ALI (18). 
Statistical analysis. We arbitrarily created groups with normal and supranormal 
EVLW (>7 mL/kg) and with LIS below and above 1. Comparisons were made with the 
Fisher's exact test and the non-parametric Mann-Whitney U test. The non-parametric 
Spearman correlation coefficient was used to express relations. Data were 
summarized as median (range). All tests were two-sided and a P<0.05 was considered 
statistically significant. 
 
Table 1. Patient characteristics 
 
Age, year       64 (51-75)   
Sex, M/F       13/3   
Prior disease 
 chronic obstructive pulmonary disease  5 
 cardiac disease     6 
Type of surgery 
 abdominal aortic aneurysm repair  12  
 coeliac/mesenteric reconstruction  4  
Aortic clamp time (n=12), min    88 (45-105)  
 
Median (range) or number of patients, where appropriate. 
 
 
RESULTS 
 
Table 1 describes the characteristics of the patients, who all survived to discharge, and 
Table 2 hemodynamic variables. The EVLW was elevated (>7 mL/kg) in 5/16 (31%) of 
patients, while the PLI was elevated in 11/16 (69%). An elevated EVLW was 
associated with an elevated ratio of EVLW to ITBV or PBV as well as with a higher PLI. 
EVLW directly correlated to GEDV index (rs=0.58, P<0.05). Table 3 shows that all 
patients had ALI, since PaO2/FiO2 (n >480) and compliance (n >80 mL/cm H2O) had 
decreased, among others. There was a difference in EVLW/PBV between high and 
low LIS patients. The latter also differed in the components of the LIS, including gas 
exchange, mechanical and radiographic abnormalities, while EVLW did not relate to 
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the components. A LIS >1 was associated with prolonged need for mechanical 
ventilatory support. Conversely, aortic clamping time was higher and tidal volume and 
compliance were lower in patients with high versus low PLI (P<0.05).  
 
DISCUSSION 
 
Our study suggests that an elevated EVLW is common after I/R associated with major 
vascular surgery and that this is mainly caused by increased capillary permeability. 
However, many of the ventilatory and radiographic abnormalities could be explained by 
atelectasis rather than mild permeability edema, since the PLI and EVLW did not differ 
among LIS groups. 
 
Table 2. Hemodynamic variables 
 
   EVLW ≤7  >7 mL/kg  LIS ≤1  >1 
    n=11   n=5   n=9   n=7  
 
Heart rate, b/min  67 (46-90)  70 (55-87)  66 (46-74)  68 (63-90) 
Mean arterial pressure, mm Hg 
    73 (63-89)  87 (68-113)  77 (66-113)  72 (63-107) 
MPAP, mm Hg  15 (13,17)  21   17   17 (13,21) 
Central venous pressure, mm Hg  
    3 (1-8)  4 (0-9)  3 (0-8)  4 (1-9) 
PCWP, mm Hg  5 (4,6) (n=2)  10 (n=1)  4 (n=1)  8 (6,10) (n=2) 
Cardiac index, L/min/m2  
    3.2 (2.1-4.5)  3.5 (2.6-4.7)  3.2 (2.7-4.5)  3.1 (2.1-4.7) 
GEDV index, mL/m2 897 (629-1168) 1065 (547-1149) 898 (547-1168) 903 (689-1149) 
Colloid osmotic pressure, mm Hg  
    16 (13-20)  14 (13-19)  16 (13-17)  16 (14-20) 
Dopamine   8   3   6   5 
Nitroglycerin   7   3   4   6 
 
Median and range or number of patients where appropriate; MPAP = mean pulmonary arterial pressure; 
PCWP = pulmonary capillary wedge pressure; GEDV = global end-diastolic volume. 
 
We have shown before that, directly after aortic surgery associated with I/R, the PLI 
increases two- to threefold, at least temporarily (9,10). This increase was accompanied 
by an elevated LIS, but there was no relation between the PLI and the LIS or its 
components (9,10). The current study supplements the former (9,10) by documenting 
an increased EVLW, even though preoperative values were not taken in the same 
patients. Thus, our current study suggests that an increase in EVLW is associated with 
mildly elevated alveolocapillary permeability, as in animal studies (8), for a given 
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hydrostatic pressure. Indeed, EVLW related to GEDVI, suggesting a contribution by 
hydrostatic factors as observed during sepsis (16), since edema formation by 
increased permeability may be promoted by hydrostatic factors (13). In any case, the 
data are consistent with absence of overt heart failure, by virtue of the inclusion 
criteria.  
 
Table 3. Respiratory variables 
 
   EVLW ≤7  >7 mL/kg  LIS ≤1  >1 
    n=11   n=5   n=9   n=7  
 
EVLW, ml/kg  5.7 (2.5-6.5)  8.2 (7.2-13.8)na 5.8 (2.5-12.7) 6.2 (5.2-13.8) 
EVLW/ITBV, mL/mL 0.22 (0.09-0.28)  0.33 (0.21-0.42)* 0.21 (0.09-0.37) 0.27 (0.21-0.42) 
EVLW/PBV, mL/mL 1.1 (0.4-1.6)  0.9 (1.2-2.7)** 1.1 (0.4-1.9)  1.5 (1.1-2.6)* 
Pulmonary leak index, 10-3 /min 
    14 (11-32)  32 (24-81)**  21 (11-81)  22 (12-32) 
PaO2, mm Hg  137 (93-189)  104 (76-220)  158 (93-220)  124 (76-161) 
PaCO2, mm Hg  37 (31-46)  4 (31-41)  35 (31-46)  36 (31-41) 
FiO2    0.4 (0.4-0.5)  0.5 (0.4-0.6)  0.4 (0.4-0.5)  0.5 (0.5-0.6)*** 
PaO2/FiO2   290 (186-461) 208 (127-537) 385 (186-537) 248 (127-316)** 
Qs/Qt, %   21 (6-45)  25 (4-10)  16 (4-45)  25 (21-40)* 
Plateau pressure, cm H2O 
    20 (12-23)  19 (15-22)  15 (12-21)  21 (15-23)** 
PEEP, cm H2O  6 (5-9)  7 (5-10)  5 (5-9)  7 (5-10) 
Tidal volume, mL  655 (450-730) 600 (430-708) 635 (430-730) 650 (500-708) 
Compliance, mL/cm H2O   
    54 (28-94)  53 (31-71)  63 (31-94)  46 (28-71) 
Radiographic alveolar densities,  
 number of quadrants 1 (0-3)  1 (0-2)  0 (0-2)  2 (1-3)** 
Lung injury score  0.7 (0.2-1.7)  1.5 (0.2-2.0)  0.7 (0.2-1.0)  1.5 (1.25-2.00)na 
Duration of ventilation, h 12 (1-87)  9 (7-49)  6 (1-32)  20 (9-87)* 
 
Median and range or number of patients where appropriate; EVLW = extravascular lung water; ITBV = 
intrathoracic blood volume; PBV = pulmonary blood volume; PaO2 = arterial PO2; FiO2 = inspiratory O2 
fraction; Qs/Qt = pulmonary venous admixture; PEEP = positive end-expiratory pressure; *P<0.05; 
**P<0.01;***P<0.005; na not applicable. To convert mm Hg to kPA, divide by 7.3. 
 
Patients with a high LIS had an elevated EVLW as fraction of PBV, suggesting that 
increased permeability was in part responsible for some of the ventilatory and 
radiographic abnormalities. However, our data also suggest that increased 
permeability edema only partially explained the postoperative increase in LIS, so that 
unmeasured factors including atelectasis must have contributed. Indeed, atelectasis is 
common in anesthetized and mechanically ventilated patients with prior normal lungs, 
and may be difficult to discern on routine supine chest radiographs rather than CT 
scans, and may persist for some time after surgery (14). We did not perform CT 
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scanning because of the transport involved. Moreover, CT scanning does not 
unequivocally differentiate between edema and atelectasis. Finally, our patients had a 
relatively uneventful postoperative course, allowing detubation on the first 
postoperative day, again arguing in favor of recruitable atelectasis. 
 
There was no relation between compliance on the one hand and EVLW or ITBV/PBV 
on the other, suggesting that atelectasis was a major cause of a low postoperative 
compliance (6,14). We did not separate total respiratory compliance in lung and chest 
wall compliances in the absence of pleural pressure measurements. Nevertheless, 
both lung and chest wall elastances may increase and compliances decrease during 
and after aortic surgery (6). The lack of relation between radiographic densities and 
EVLW may agree with the literature (12,13), and this may thus point again to, mainly 
basal, atelectatic areas. 
 
In conclusion, our results suggest that, directly after major vascular surgery-associated 
I/R, mild and 'subclinical' pulmonary edema formation is common and mainly caused 
by increased permeability, in the absence of overt heart failure. However, increased 
permeability edema only partly contributes to gas exchange, mechanical and 
radiographic abnormalities, suggesting atelectasis as a contributory factor to lung injury 
and need for mechanical ventilatory support, after surgery.  
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ABSTRACT 
 
Objective. To study the relation between gas exchange abnormalities and increased 
permeability edema in sepsis-associated acute lung injury/acute respiratory distress 
syndrome (ALI/ARDS) by pneumonia or an extrapulmonary origin. 
Design. A prospective observational study.  
Patients. Twenty-two consecutive mechanically ventilated patients with sepsis-related 
ALI/ARDS from pneumonia (n=12) or extrapulmonary sources (n=10). 
Setting. Intensive care unit of an university hospital. 
Measurements and results. Protein permeability was assessed non-invasively over 
the lungs with help of 67Ga-transferrin and 99mTc-red blood cells (pulmonary leak index 
PLI, n< 14.1 x 10-3/min) and extravascular lung water (EVLW) by the thermal-dye 
transpulmonary dilution technique, also allowing assessment of cardiac output. 45% of 
patients had asymmetric lung injury on plain radiographs, associated with an elevated 
PLI difference between lungs, while the lung-averaged PLI was above normal in all 
patients and the EVLW in only 68%. The PLI directly correlated with venous admixture, 
so that patients with a PLI > 40 x 10-3/min had a higher venous admixture than those 
with a lower PLI, at similar EVLW. The PLI related to the ratio of EVLW to pulmonary 
or intrathororacic blood volume (PBV, ITBV). Pneumonia was associated with a high 
PLI, more extensive radiographic pulmonary densities, higher venous admixture and 
cardiac index, and lower oxygenation ratio than extrapulmonary sepsis, independently 
of EVLW (and its ratio to PBV and ITBV).  
Conclusion. The data support that in mechanically ventilated patients with sepsis-
induced ALI/ARDS, increased venous admixture is better explained by a lung vascular 
injury than by edema. They also suggest that the vascular injury is greater in 
pneumonia than in extrapulmonary sepsis.  
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INTRODUCTION 
 
Acute lung injury (ALI) progressing to acute respiratory distress syndrome (ARDS) 
during sepsis, a major risk factor for ALI/ARDS, is characterized by pulmonary 
radiographic and mechanical abnormalities and impaired oxygenation, thought to 
originate from increased permeability edema following a lung vascular injury. The latter 
is reflected by an elevated protein permeability, as measured by the non-invasive 
double radionuclide 67Ga-transferrin pulmonary leak index (PLI) (1-4). During 
pneumonia and ALI/ARDS, indeed, the PLI may moderately relate to the lung injury 
score (LIS), which takes the clinical manifestations into account (5), but hardly to its 
components including impaired oxygenation, while the extent of non-areated tissue on 
computer tomography (CT) scans may directly relate to venous admixture during 
ALI/ARDS (6). In the latter studies, however, lung edema was not directly assessed 
and non-areated tissue could also include consolidation or atelectasis (7). This 
differentiation can be important from a therapeutic point of view, whereas the role of 
edema may differ in direct and indirect ALI/ARDS (8,9).  
 
The transpulmonary thermal-dye dilution technique allows estimating extravascular 
lung water (EVLW), but about one third percent of ALI/ARDS patients may have a 
normal EVLW, and EVLW may thus poorly correlate with radiographic pulmonary 
densities (10-12). It is unknown whether this could be attributed in part to inaccessibility 
of the thermal indicator in direct lung injury, thereby underestimating lung edema (10-
17). Radiographic pulmonary densities in the absence of an elevated EVLW could also 
be explained by consolidation or atelectasis. Moreover, the ratio of EVLW to 
pulmonary or intrathoracic blood volume (PBV, ITBV), has been proposed as an index 
of permeability, but this is yet unproven (12,18-20) and the ratio has been shown to be 
influenced also by a low plasma colloid osmotic pressure, at least after cardiac surgery 
(21). 
 
To evaluate the contribution of increased permeability, edema and origin of sepsis-
induced ALI/ARDS to impaired oxygenation, we measured, in 22 consecutive 
mechanically ventilated patients in the intensive care unit (ICU) with pneumonia or 
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extrapulmonary sepsis-induced ALI/ARDS, the EVLW (to PBV and ITBV ratio), the PLI 
and ventilatory and gas exchange variables (5).  
 
PATIENTS AND METHODS 
 
This is a prospective study, approved by the Ethical Committee of the Vrije Universiteit 
medical centre, involving 22 consecutive mechanically ventilated patients with sepsis 
and ALI/ARDS in the ICU, given written informed consent (from patient or relatives), in 
a 24 month period. The inclusion criteria were the presence of a pulmonary artery 
(n=3) or central venous catheter (n=19), within 24 hours of meeting criteria for severe 
sepsis and ALI/ARDS. Severe sepsis was defined by abnormal body temperature (>38 
°C, <36 °C), abnormal white blood cell counts (<4, >12 x 109/L or >10% immature 
bands), hypotension and (increasing) need for vasopressor/inotropic therapy, and a 
clinically evident and microbiologically proven source of infection. ICU-acquired sepsis 
was defined as sepsis developing after two days in the ICU. ALI was defined by a LIS 
>0 and ≤2.5 and ARDS by a LIS>2.5 (5), in the absence of overt congestive heart 
failure or overhydration, defined by a CVP >12 mm Hg or >17 mm Hg if PEEP >15 cm 
H2O. Pneumonia was defined by purulent sputum with a positive blood/tracheal 
aspirate culture, temperature above 38 °C or below 36 °C and recent-onset densities 
on the chest X-ray. Other origins of sepsis were defined on the basis of clinical signs 
and symptoms and positive local and/or blood cultures. Exclusion criteria were an age 
above 79 years, pregnancy and a life expectancy less than 24 hours. Radial artery, 
central venous and pulmonary artery catheters were inserted for hemodynamic 
measurements and blood sampling. After tracheal intubation, the lungs were pressure-
controlled ventilated with a tidal volume (Vt) of 6-8 mL/kg resulting in an end-tidal CO2 
concentration between 4 and 5%, using an O2-air mixture and positive end-expiratory 
pressure of 5 cm H2O or more, when needed (I:E 1:2). We did not routinely attempt to 
recruit potential atelectatic areas. Patients were otherwise treated according to our 
guidelines for hemodynamic optimization, vasopressor/inotropic support with 
norepinephrine or dopamine, infection control with antibiotics guided by sensitivities of 
causing microorganisms, and continuous renal replacement techniques when indicated 
on clinical grounds. The PLI was measured as described previously (1-4). In brief, 
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autologous red blood cells were labeled with 99mTc (11 MBq, physical half-life 6h; 
Mallinckrodt Diagnostica, Petten, The Netherlands). Transferrin was labeled in vivo, 
following i.v. injection of 67Ga-citrate, 4.5 MBq (physical half-life 78 h; Mallinckrodt 
Diagnostica, Petten, The Netherlands). Patients were in the supine position and two 
scintillation detection probes (Eurorad C.T.T., Strasburg, France) were positioned over 
the right and left lung apices. Starting at the time of injection of 67Ga, radioactivity was 
detected every minute, during 30 minutes. The count rates were corrected for 
background radioactivity, physical half-life and spill-over and expressed as counts per 
minute (CPM) per lung field. Until 30 minutes after 67Ga injection, blood samples (2 mL 
aliquots) were taken. Each blood sample was weighed and radioactivity was 
determined with a single well well-counter, corrected for background, spillover and 
decay (LKB Wallac 1480 WIZARD, Perkin Elmer, Life Science, Zaventem, Belgium). 
Results were expressed as CPM/g. For each blood sample, a time-matched CPM over 
each lung was taken. A radioactivity ratio was calculated, (67Galung/99mTclung)/ 
(67Gablood/99mTcblood), and plotted against time. The PLI was calculated, using linear 
regression analysis, from the slope of increase of the radioactivity ratio divided by the 
intercept. The PLI represents the transport rate of 67Ga from the intravascular to the 
extravascular space of the lungs and is therefore a measure of pulmonary vascular 
permeability (1-3). The values for both lung fields were averaged, but the difference 
between the radiographically most affected and least affected side, in case of 
asymmetric injury, was calculated also. The upper limit of normal for the PLI is 14.1 x 
10-3/min and the measurement error is about 10% (1-3). The PLI typically exceeds 40 
x 10-3/min in ARDS (1-3). 
 
The EVLW was measured with help of the thermal-dye technique (13,14,22). A 4F 
introducing sheath (Arrow, Reading, USA) was inserted into the femoral artery, for use 
in the study protocol, in each patient. A 3F fiberoptic thermodilution catheter was 
inserted in the femoral artery sheath. Fifteen mL of ice cold indocyanine green (ICG), 1 
mg/mL D5W, was injected in a central vein and the thermal-dye dilution curve obtained 
at the femoral artery (COLD Z-021, Pulsion Medical Systems, Munich, Germany). This 
allowed calculation of the transpulmonary cardiac output, the intrathoracic blood 
volume (ITBV), the global end-diastolic volume (GEDV), the pulmonary blood volume 
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(PBV) and the extravascular thermal volume in the lungs as a measure of EVLW 
(normal <7-10 mL/kg) (13,14,17,22). EVLW is typically two- to threefold elevated in 
case of overt (radiographic) pulmonary edema (10,12-14,17,22). The normal ratio of 
EVLW/ITBV (mL/mL) is 0.2 to 0.3 and the normal EVLW/PBV ratio is about 1, and the 
indices have been proposed, but not proven, to reflect permeability (12,18,20). 
Measurements were done in duplicate and averaged. The cardiac output and GEDV 
were indexed to body surface area (cardiac index, CI; GEDVI) and EVLW to kg. 
Hemodynamics were included in the study since they may affect pulmonary variables. 
The LIS was calculated from the number of quadrants on the chest radiograph with 
densities, the PEEP level, the arterial PO2 (PaO2)/inspiratory O2 fraction (FiO2) and the 
total dynamic respiratory compliance (5). The compliance was calculated from tidal 
volume/(plateau pressure-PEEP), mL/cm H2O. The chest radiograph was scored by a 
consultant radiologist, blinded to the study, who evaluated the number of quadrants 
with alveolar densities, ranging from 0 to 4. Moreover, asymmetric injury and evidence 
for basal atelectasis were judged.  
Protocol. Demographics were recorded, including variables for calculation of the acute 
physiology and chronic health evaluation (APACHE-II) score, measurements of EVLW, 
67Ga-transferrin PLI and hemodynamics were performed, and an anteroposterior chest 
radiograph was made. Hemodynamic variables were measured after calibration and 
zeroing to atmospheric pressure at mid-chest level (TramscopeR, Marquette, Wisc., 
USA). CVP was taken at end-expiration, with patients in the supine position. Arterial 
blood samples were obtained for determinations of partial O2/CO2 pressures and O2 
saturations (Rapidlab 865, Bayer Diagnostics, Tarrytown, NY, USA, at 37 °C). Mixed 
(n=3) or central (n=19) venous blood was taken simultaneously for measurement of 
partial pressures and saturations. Venous admixture was calculated according to 
standard formulae, with central venous substituting for mixed venous blood in the 
absence of a PA catheter (23). The plasma colloid osmotic pressure (COP) was 
measured by a membrane osmometer (Osmomat 050, Gonotex, Berlin, Germany, 
molecular cut-off at 20 kDa, normal about 24 mm Hg). The FiO2, tidal volume, plateau 
inspiratory pressure and PEEP (cm H2O) were taken from the ventilator. Doses of 
vasoactive drugs were recorded. Patients were taken care of by intensive care 
physicians not involved in the study and followed until extubation and discharge/death 
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in the ICU. Mortality is ICU mortality. 
Statistical analysis. We compared groups with pneumonia and extrapulmonary 
sepsis, with and without radiographic evidence for atelectasis, and those dichotomised 
according to relevant values of PLI, EVLW (7 and 10 mL/kg), LIS, asymmetric/ 
symmetric injury and absence/presence of atelectasis, with help of the non-parametric 
Mann-Whitney U test for continuous and with help of the Fisher's exact test for 
categorical data. The Spearman correlation coefficient was used to express relations. 
The area (AUC) under the receiver-operating characteristic curve (ROC) was 
evaluated for the predictive value of variables for mortality. Exact P values below 0.10 
are given and a P<0.05 was considered to indicate statistical significance. All tests 
were two-sided. Data were summarised as median and range.  
 
Table 1. Patient characteristics 
 
Age, year    59 (45-77) 
Sex, M/F    16 (73)/6 (27) 
Underlying disease 
cardiac surgery    3 (14) 
other surgery    6 (27) 
acute pancreatitis    1 (4) 
diabetes mellitus    4 (18) 
renal insufficiency    1 (4) 
malignancy    4 (18) 
chronic lung disease    2 (9) 
Source of sepsis 
 pneumonia     12 (55) 
 abdominal     4 (18) 
 urogenital     1 (4) 
 blood/catheter    2 (9) 
 other       3 (14) 
Culture results 
 Blood Gram-     1 (4) 
 Gram +     5 (23) 
 fungal      1 (4) 
 Local*Gram-     7 (32) 
 Gram +     4 (18) 
 fungal      4 (18) 
ICU-acquired sepsis    7 (32)  
APACHE II score    15 (6-23) 
Temperature, °C    37.0 (35.4-38.8) 
Arterial PCO2, mm Hg    40 (32-67) 
Renal replacement therapy   2 (9)  
Vasopressor/inotropic therapy   19 (86) 
Interval between admission and study, days 1 (0-41)  
Mortality in ICU    7 (32)  
 
Median (range) or number of patients, where appropriate. *When blood-culture negative. 
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RESULTS 
 
Table 1 describes the patient characteristics and Table 2 hemodynamic and 
pulmonary data. While only 67% of ALI and 71% of ARDS patients had an elevated 
EVLW (>7 mL/kg), all patients had a PLI above normal.  
ALI versus ARDS. Patients with ALI (LIS≤2.5) and ARDS (LIS>2.5) did not differ in 
PLI and EVLW, but in oxygenation, which was worse in ARDS, and in PEEP and 
plateau pressures, which were higher (Table 2). In ARDS patients, the PLI tended to 
be higher (n=5, above 47 x 10-3/min) during pneumonia than during extrapulmonary 
sepsis (n=2, below 47 x 10-3/min, P=0.090).  
Asymmetric versus symmetric ALI/ARDS. It is shown that the interlung difference in 
PLI was greater in case of radiographic asymmetric than symmetric lung injury, which 
otherwise did not differ. 
Pneumonia versus extrapulmonary sepsis. Table 3 shows that patients with 
pneumonia had a higher cardiac output, more radiographic densities, greater venous 
admixture and lower oxygenation ratio than patients with extrapulmonary sepsis. The 
frequency of high PLI's was also elevated in the former.  
Severely versus moderately elevated PLI. Groups differed in venous admixture and 
frequency of pneumonia (Table 3). 
High versus low EVLW and evidence for basal atelectasis. Patients with EVLW 
>10 (n=9) or <10 mL/kg (n=13), or with (n=7) and without (n=15) radiographic evidence 
for basal atelectasis, did not differ in pulmonary variables, except for a lower tidal 
volume and compliance (P=0.023) in patients with atelectasis.  
ICU-acquired versus non-ICU acquired sepsis. In the former group (n=7), the PLI 
and venous admixture were higher and SaO2 was lower than in the latter group (n=15, 
P=0.047 or lower), while EVLW (and other pulmonary variables) did not differ.  
Correlations. The oxygenation ratio inversely correlated (rs=-0.85, P<0.0001) to 
venous admixture. There was a direct relation between PLI and venous admixture 
(rs=0.42, P=0.050). There was also a direct relation (Fig. 1) between the PLI and the 
EVLW to PBV or ITBV ratio and the latter to radiographic pulmonary densities, 
particularly in extrapulmonary sepsis and pneumonia (rs=0.71, P=0.022, and rs=0.67, 
P=0.017 in these subgroups, respectively). In the group as a whole, there were no 
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statistically significant relations between EVLW (to blood volume ratios), radiographic 
densities, gas exchange and mechanical abnormalities, nor between PLI and 
radiographic densities and mechanical abnormalities.  
 
Table 2. ALI/ARDS and radiographic symmetry 
 ALI (LIS≤2.5) ARDS (LIS>2.5) Asymmetric  Symmetric  
 n=15 n=7 n=10 n=12  
 
Hemodynamic 
HR, /min 104 (46-139) 92 (64-132) 106 (66-139) 86 (46-130) 
MAP, mm Hg 75 (61-95) 70 (60-89) 73 (61-95) 73 (60-89) 
CVP, mm Hg 6 (0-16) 9 (4-13)2 8 (4-16) 6 (0-13)1 
GEDVI, mL/m2 884 (556-1446) 818 (652-1106) 904 (591-1447) 788 (556-1196) 
CI, L/min/m2 3.4 (2.3-5.5) 3.7 (2.9-6.6) 3.9 (2.7-6.6) 3.5 (2.3-5.3) 
COP, mm Hg 16 (10-20) 17 (15-19) 16 (10-19) 16 (13-20) 
Dopamine, mg/h 24 (0-52) 32 (20-56) 28 (0-52) 24 (0-56) 
Norepinephrine, mg/h 0.2 (0-1.2) 0 (0-1.0) 0.2 (0-1.2) 0 (0-0.8) 
 
Pulmonary 
PLI, x 10-3/min 56 (17-217) 49 (39-204) 50 (28-217) 53 (17-204) 
Difference, % 9 (0-31) 5 (2-29) 11 (5-31) 4 (1-29)5 
PLI >40 x 10-3/min 10 (67) 6 (86) 7 (70) 9 (75) 
EVLW, mL/kg 7.1 (1.9-18.1) 14.9 (4.1-33.9) 9.7 (4.4-21.3) 7.3 (1.9-33.9) 
EVLW >10 mL/kg 5 (33) 4 (57) 5 (50) 4 (33) 
EVLW/ITBV 0.27 (0.10-0.64) 0.68 (0.13-0.91) 0.30 (0.13-0.85) 0.27 (0.10-0.91) 
EVLW/PBV 1.4 (0.5-19.6) 3.4 (0.5-17.3) 1.6 (0.5-7.3) 1.5 (0.5-19.6) 
PaO2, mm Hg 109 (65-141) 97 (82-108)4 97 (65-119) 107 (82-141) 
SaO2, % 97 (93-99) 97 (94-98) 97 (93-99) 97 (96-98) 
FiO2, % 50 (40-61) 54 (49-75)3 55 (40-65) 49 (41-75) 
PaO2/FiO2 235 (110-302) 164 (140-216)7 188 (110-293) 213 (140-302) 
Venous admixture, % 26 (9-41) 33 (30-42)3 32 (11-49) 27 (9-48) 
Plateau pressure, cm H2O 
 24 (14-40) 33 (30-42)6 29 (18-39) 32 (15-42) 
Tidal volume, mL 550 (460-800) 590 (535-680) 580 (460-800) 550 (470-680) 
PEEP, cm H2O 10 (1-22) 16 (13-20)7 11 (1-22) 11 (5-20) 
Compliance, mL/cm H2O 41 (24-62) 35 (25-45)7 37 (24-62) 36 (25-61) 
Number of quadrants 2 (0-4) 2 (1-4)7 2 (1-3) 2 (0-4) 
Lung injury score 2.0 (0.7-2.5) 3.0 (2.7-3.5)7 2.4 (1.5-3.0) 2.3 (0.7-3.5) 
Pneumonia 7 (47) 5 (71) 3 (30) 7 (58) 
ARDS na  na 2 (20) 5 (42) 
Length of stay, days 10 (1-58) 21 (6-93) 13 (1-51) 11 (6-93) 
Mortality 5 (30) 2 (29) 3 (33) 4 (33) 
 
Median (range) or number of patients, where appropriate. Abbreviations: HR = heart rate, MAP = mean 
arterial pressure, CVP = central venous pressure, GEDVI = global end-diastolic volume index, CI = 
cardiac index, COP = colloid osmotic pressure, PLI = pulmonary leak index, EVLW = extravascular lung 
water, ITBV = intrathoracic blood volume, PBV = pulmonary blood volume, P/SaO2 = arterial O2 
pressure/saturation, FiO2 = inspiratory O2 fraction, PEEP = positive end-expiratory pressure, ARDS = 
acute respiratory distress syndrome. Exact P values <0.10 are given: 1P=0.080, 2P=0.078, 3P=0.056, 
4P=0.047, 5P=0.025, 6P=0.012, 7P=not applicable. 
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Table 3. Sepsis and pulmonary leak index (PLI) 
 
 Sepsis  PLI  
 Pneumonia Extrapulmonary <40 >40 x10-3/min 
 n=12 n=10 n=6 n=16 
 
Hemodynamic 
HR, /min 98 (64-139) 86 (46-130) 80 (46-130) 104 (64-139)4 
MAP, mm Hg 71 (60-86) 76 (64-95) 80 (71-89) 69 (60-95)7 
CVP, mm Hg 7 (3-13) 6 (0-16) 5 (3-16) 7 (0-13) 
GEDVI, mL/m2 909 (556-1214) 741 (591-1447) 878 (725-1447) 867 (556-1196) 
CI, L/min/m2 4.5 (2.9-6.6) 3.1 (2.3-5.3)8 3.3 (2.3-5.4) 3.6 (2.6-6.6) 
COP, mm Hg 16 (10-19) 16 (13-20) 16 (10-19) 16 (12-20) 
Dopamine, mg/h 28 (0-56) 24 (0-40) 22 (0-40) 28 (0-56) 
Norepinephrine, mg/h 0.5 (0-1.2) 0.2 (0-0.8) 0.05 (0-0.4) 0.1 (0-1.2) 
 
Pulmonary 
PLI, x 10-3/min 55 (35-204) 42 (17-217) 30 (17-39) 58 (45-217)12 
Most-least affected, % 
PLI > 40 x 10-3/min 11 (92) 5 (50)5 na na 
EVLW, mL/kg 9.0 (3.6-33.9) 7.8 (1.9-14.9) 7.8 (1.9-13.1) 8.5 (3.6-33.9) 
EVLW >10 mL/kg 6 (50) 3 (33) 2 (33) 7 (44) 
EVLW/ITBV 0.29 (0.13-0.91) 0.28 (0.10-0.68) 0.24 (0.10-0.32) 0.32 (0.13-0.91)2 
EVLW/PBV 15 (0.5-17.3) 1.6 (0.5-19.7) 1.2 (0.5-1.8) 1.9 (0.5-19.2)2 
PaO2, mm Hg 97 (65-141) 112 (82-124) 106 (82-118) 101 (65-141) 
SaO2, % 97 (93-98) 97 (96-99)3 97 (96-99) 97 (93-96) 
FiO2, % 53 (40-75) 48 (40-61)3 46 (40-61) 50 (41-75) 
PaO2/FiO2 183 (110-256) 235 (164-302)6 219 (164-293) 197 (110-302) 
Venous admixture, % 34 (19-49) 25 (9-33)11 24 (9-30) 32 (16-49)9 
Plateau pressure, cm H2O 
 31 (14-42) 30 (16-40) 21 (14-35) 31 (15-42) 
Tidal volume, mL 595 (500-800) 550 (460-620)1 550 (460-620) 590 (470-800) 
PEEP, cm H2O 12 (1-20) 11 (6-22) 10 (1-22) 12 (5-20) 
Compliance, mL/cm H2O  
 37 (27-56) 36 (25-62) 42 (35-62) 36 (25-61) 
Number of quadrants 3 (2-4) 1 (0-4)10 2 (1-4) 2 (0-4) 
Lung injury score 2.5 (1.5-3.5) 2.1 (0.7-2.7) 2.1 (1.5-2.7) 2.5 (0.7-3.5) 
Pneumonia na  na 1 (16) 11 (69)5 
ARDS 5 (42) 2 (20) 1 (16) 6 (37) 
Length of stay, days 12 (1-51) 17 (6-93) 10 (6-93) 13 (1-58) 
Mortality 5 (42) 2 (20)  0  7 (44) 
 
Median (range) or number of patients, where appropriate. Abbreviations: HR = heart rate, MAP = mean 
arterial pressure, CVP = central venous pressure, GEDVI = global end-diastolic volume index, CI = 
cardiac index, COP = colloid osmotic pressure, PLI = pulmonary leak index, EVLW = extravascular lung 
water, ITBV = intrathoracic blood volume, PBV = pulmonary blood volume, P/SaO2 = arterial O2 
pressure/saturation, FiO2 = inspiratory O2 fraction, PEEP = positive end-expiratory pressure, ARDS = 
acute respiratory distress syndrome. Exact P values <0.10 are given: 1P=0.095, 2P=0.085, 3P=0.069, 
4P=0.059, 5P=0.056, 6P=0.05, 7P=0.040, 8P=0.025, 9P=0.017, 10P=0.014, 11P=0.003, 12P=not applicable.  
 
 
ICU mortality. There was a tendency for a predictive value of PLI, and not of EVLW, 
for mortality (ROC AUC 0.73, 95% CI 0.51-0.90, P=0.08), since all patients who died 
(n=7, 32%) had a PLI >40 x 10-3/min only. 
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DISCUSSION 
 
Our results suggest that, in mechanically ventilated patients with sepsis and 
ALI/ARDS, increased venous admixture and impaired oxygenation are better explained 
by a lung vascular injury than by edema, even though a lung vascular injury relates to a 
rise in EVLW to PBV or ITBV ratio and the latter bears some relation to radiographic 
pulmonary densities. Moreover, the PLI is more often elevated, venous admixture is 
higher and radiographic densities are more extensive during pneumonia than during 
extrapulmonary sepsis, particularly when acquired in the ICU. The data also argue in 
favour of extensive radiographic pulmonary densities caused by consolidations rather 
than by edema or atelectasis, during pneumonia. 
 
Absent relations among edema (EVLW), radiographic densities and gas exchange 
abnormalities in the lungs, may be due to the relatively small number of patients 
studied. However, other authors have also described absent or poor relations between 
radiographic pulmonary densities, gas exchange and EVLW (10,12,14), even though 
basal pulmonary densities on CT scan may directly correlate to venous admixture, 
attributable to alveolar collapse and/or edema in non-aerated tissue, during acute 
respiratory failure (6,7). The associations between vascular injury and venous 
admixture and between radiographic pulmonary densities to EVLW only when 
normalised for blood volumes (and not to gas exchange/mechanical disturbances) 
otherwise favour that the greater vascular injury during pneumonia resulted in 
consolidation rather than edema or alveolar collapse. The absence of any differences 
among patients with or without evidence for basal atelectasis also argues in favour of 
consolidations induced by vascular injury, even though plain radiography may 
underestimate dorsal atelectasis as compared to CT scanning (6,7). In turn, this may 
partly explain less response of oxygenation during attempts to recruit collapsed alveoli 
with high ventilatory pressures in pneumonia than in extrapulmonary ALI/ARDS, as 
suggested before in animal and clinical studies (8,9,24). We did not perform ventilatory 
recruitment maneuvers in our patients to verify this hypothesis, in the absence of 
uniformly accepted techniques to compare responses. We also did not perform CT 
scanning because of the transport involved and the poor differentiation by the 
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technique between edema, atelectasis and collapse (7).  
 
We nevertheless cannot completely exclude that during pneumonia the edema fluid 
was less accessible to the thermal indicator than during extrapulmonary sepsis (16,17). 
Indeed, experimental literature suggests that, as compared to the gravimetric methods, 
the double indicator dilution method can somewhat underestimate pulmonary edema 
in direct, as opposed to indirect ALI/ARDS (16,17). That increased permeability was 
only weakly linked to edema (Fig. 1), may also relate, in part to sampling error by the 
radionuclide probes, and to the concomitant effect of Starling forces that also affect 
edema formation in the lungs. In any case, EVLW was normal in about 30% of 
patients, in exact agreement with the literature, showing that the EVLW may be 
normal, even during ARDS, thereby again arguing against edema to explain 
radiographic pulmonary densities (11-13,15).  
 
 
 
 
 
 
 
 
 
 
Figure 1. Relation between pulmonary leak index (PLI) and ratio between extravascular lung water 
(EVLW) and intrathoracic blood volume (ITBV), which is normally 0.2-0.3, in patients with pneumonia or 
sepsis. rs=0.46, P=0.032. A similar direct relation was observed for PLI versus EVLW/pulmonary blood 
volume. Open symbols: extrapulmonary sepsis; closed symbols: pneumonia.  
 
The EVLW to ITBV or PBV ratios have been suggested to reflect increased 
permeability edema, but this has not yet been validated before (12,18-20), even 
though we already noted high ratios concomitantly with an elevated PLI after major 
vascular surgery (19). In contrast, a high ratio may also result from a low plasma 
colloid osmotic pressure promoting fluid filtration into the lungs, rather than increased 
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permeability, at least after cardiac surgery (21). Our present study indicates (for the 
first time) that there is indeed a moderate and direct relation between independently 
measured pulmonary protein permeability and EVLW ratios, particularly during 
extrapulmonary sepsis and independently of plasma colloid osmotic pressure.  
 
Conversely, our current data suggest that the PLI is a greater determinant of the 
manifestations of sepsis-induced lung injury, than the EVLW. In contrast to the EVLW, 
the PLI was elevated in all patients. Moreover, the PLI had a greater predictive value 
for outcome than EVLW, which was of prognostic significance in critical illness and 
ARDS in some but not in other studies (12-14). In a previous study, we reported that 
patients with pneumonia had an increasing PLI when progressing from ALI to ARDS, 
and a high PLI at most affected than least affected sides (3). In the current study, we 
confirm these observations and demonstrate that, venous admixture is greater during 
pneumonia than during extrapulmonary sepsis, associated with more pulmonary 
radiographic densities and a higher frequency of an increased PLI. The relation of 
venous admixture to the PLI indeed suggests that, during pneumonia, the increase in 
venous admixture was not solely caused by a higher cardiac output. That total 
respiratory compliance does not differ between ARDS types has been reported before, 
where direct ARDS (pneumonia) may be associated with low lung compliance and 
indirect ARDS (extrapulmonary sepsis) with low chest wall compliance (9). We 
measured total dynamic respiratory compliance and did not separate lung and chest 
wall contributions. A limitation of the study is the derivation of venous admixture from 
central venous rather than mixed venous blood. Other investigators, however, have 
shown that, in spite of some absolute differences when lower body O2 extraction is 
lower than in the superior caval vein, changes in central venous track changes in 
mixed venous hemoglobin saturation (23). In our patients, the oxygenation ratio 
inversely correlated to venous admixture, suggesting that central venous blood 
saturation was a major determinant of arterial oxygenation.  
 
In conclusion, our study in mechanically ventilated patients with sepsis-induced 
ALI/ARDS suggests that a lung vascular injury with consolidation rather than edema or 
atelectasis, is largely responsible for impaired oxygenation. This may hamper alveolar 
 70 
recruitment (8,9), may limit the effect of diuretics (25) and calls for anti-inflammatory 
strategies (26). 
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ABSTRACT 
 
Objective. To study the effects on volume expansion and myocardial function of 
colloids or crystalloids in the treatment of hypovolemia after cardiac and major vascular 
surgery. 
Design and setting. A single-center, single-blinded, randomized clinical trial at the 
intensive care unit of a university hospital. 
Patients and methods. Patients with low filling pressures and hypotension after 
cardiac or major vascular surgery were subjected to a 90-min filling pressure-guided 
fluid challenge, targeting a central venous pressure (CVP) of 13 mm Hg or a 
pulmonary capillary wedge pressure (PCWP) of 15 mm Hg, with saline 0.9% (n=16), or 
the colloid solutions modified fluid gelatin 4% (n=16), hydroxyethyl starch 6% (HES 
200/0.5, n=17) or albumin 5% (n=18). Biochemical variables and hemodynamics 
(transpulmonary thermodilution) were measured. 
Results. More saline than colloids was infused (P<0.005). Saline decreased colloid 
osmotic pressure (COP), while increasing in the other groups (P<0.001). Plasma 
volume increased less in saline than in the colloid groups. Cardiac index increased by 
median 13% (ns) in the saline group, and 22% in the colloid groups (P<0.005 between 
groups). The rise in left ventricular stroke work index was greater in the colloid than in 
the saline groups. Colloids were equally effective. The rise in cardiac index related to 
the rise in plasma volume and global end-diastolic volume, confirming plasma volume 
and preload augmentation by pressure-guided fluid loading.  
Conclusion. After cardiac or major vascular surgery, pressure-guided fluid 
responsiveness is dependent on the type of fluid used. Colloid fluid loading leads to a 
greater increase in preload-recruitable cardiac and left ventricular stroke work indices 
than that with saline, because of greater plasma volume expansion following an 
increase in plasma colloid osmotic pressure.  
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INTRODUCTION 
 
Hypovolemia is relatively common after major surgery, including cardiac and vascular 
surgery, and associated with major fluid shifts and hypotension (1,2). Fluid loading is 
the mainstay of treatment, but the choice among the available fluids is unclear, even 
though addressed by several studies in cardiac surgery (3-14) or vascular surgery 
patients (15-20). In any case, (colloid) fluid loading may lead to an increase in cardiac 
index in surgical patients and may reduce intensive care unit and hospital lengths of 
stay (2,10,21).  
 
The colloid-crystalloid controversy refers to the ongoing debate on the relative merits 
and detriments of resuscitation from hypovolemia with infusion of colloid or crystalloid 
solutions (22-24). This includes the role of plasma colloid osmotic pressure (COP) in 
retaining fluids intravascularly and in the allegedly greater speed and extent by which 
colloids, maintaining COP, restore plasma volume and blood flow as opposed to 
crystalloids, which dilute plasma proteins and lower COP (22-24). Indeed, it is 
commonly believed, but also doubted, that 2-3 times more crystalloid than colloid fluid 
is needed to restore and maintain filling pressures in the treatment of hypovolemia, 
and the ratio of crystalloid to colloid fluid volume to maintain intravascular filling may 
range from 1 to 5, after cardiac or major vascular surgery (6,8,10,12,14-18,20,24,25). 
The colloid-crystalloid controversy may also stem in part from the time-dependency of 
fluid effects and the monitored end point for adequacy of fluid resuscitation used. 
Filling pressures of the heart may be poor indicators of cardiac preload and fluid 
responsiveness and global end-diastolic volume assessed from transpulmonary 
thermodilution, may be superior in that respect (12,26-31). Finally, the colloid-colloid 
controversy refers to the potential of artificial colloids to replace human protein colloids 
(3-5,7-11). Indeed, starch infusions may result in better cardiac performance than 
those of saline or even protein colloids (32), which may have negative inotropic effects 
via binding of circulating calcium (33). Starches may ameliorate cardiac 
ischemia/reperfusion injury, at least in animals (34). 
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For the current study, we hypothesized that colloid fluid loading, by maintaining plasma 
COP, results in a greater plasma volume expansion and cardiac output elevation with 
time than that with saline, after cardiac or vascular surgery. We also hypothesized that 
exogenous colloids would perform similar to albumin in this respect. We thus 
compared saline with various commonly used colloids and evaluated plasma COP, 
plasma volume and cardiac performance, using a standard pressure-guided fluid 
challenge protocol over 90 min (35), verified by transpulmonary thermodilution preload 
measurements (12,26-31).  
 
Table 1. Fluid challenge protocol 
 
Central venous pressure, mm Hg: 
At start:     ≤ 8    200 mL/ 10 min 
     < 12    100 mL/ 10 min 
     = 12    50 mL/ 10 min 
During infusion:   increase > 5   Stop 
After 10 min:    increase ≤ 2   Continue 
     2 < increase < 5  Wait 10 min 
     increase > 5   Stop 
After 10 min waiting  increase > 2   Stop  
     increase ≤ 2   Repeat 
Pulmonary capillary wedge pressure, mm Hg: 
At start    ≤ 10    200 mL/ 10 min 
     < 14    100 mL/ 10 min 
     = 14    50 mL/ 10 min 
During infusion   increase > 7   Stop 
After 10 min    increase ≤ 3   Continue 
     3 < increase < 7  Wait 10 min 
     increase > 7   Stop 
After 10 min waiting  increase > 3   Stop 
     increase ≤ 3   Repeat 
 
Modified from Weil MH, et al. Anesth Analg 1979; 58: 124-132 (ref 35). 
 
PATIENTS AND METHODS 
 
This study is a prospective, stratified, randomized, single-blinded and single-centre 
clinical trial. The study was approved by the Ethical Committee of the Vrije 
Universiteit Medical Center and was performed in accordance with the ethical 
standards laid down in the 1964 Declaration of Helsinki. Written informed consent 
was obtained in each of the 89 eligible patients, pre-operatively. The hospital 
pharmacy assigned the patients randomly, via the sealed envelop method, to various 
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groups, after stratification between cardiac (n=40) or major vascular surgery (n=28). 
Of the 89, 68 patients fulfilled the study criteria at the arrival at the intensive care unit 
(ICU) post-operatively. One cardiac patient assigned to saline, however, was 
excluded because of technical failures and one patient assigned to the gelatin group 
inadvertedly received albumin. Hence, 67 consecutive patients were included in the 
study, leaving 16 saline, 16 gelatin, 17 hydroxyethyl starch and 18 albumin-loaded 
patients.  
 
Table 2. Patient characteristics 
 
       NaCl 0.9%   Gelatin 4%  HES 6%   Albumin 5%  
       n=16     n=16   n=17    n=18 
 
Age, year   64 (53-75)  63 (41-75)  66 (38-74)  62 (51-74) 
Sex, M/F   14/2   16/0A     10/7A     14/4A  
APACHE II    8 (3-17)    8 (2-18)    9 (2-14)    9 (3-15) 
Cardiac surgery  9      9      10      11 
Vascular surgery  7      7      7      7  
Type of surgery    
  CABG   4      4      6      6  
  OPCABG   2      2      2      2 
  AVR    1      0      1      2 
  CABG + AVR  2      2      0      1 
  ASD repair   0      1      1      0 
  AAA    6      7      2      4 
  TAA    1      0      3      1 
  MS    0      0      2      2 
CPB, min/N   122 (86-188)/8  96 (85-190)/7  111 (40-168)/11 115 (77-198)/10 
Aortic clamping time, min/N 
    95 (43-140)/14  90 (31-175)/14  76 (26-102)/13  70 (49-113)/14 
Inotropic support, µg/kg/min/N 
  Dopamine   2 (0-17)/10   2 (0-8)/14   0.5 (0-10)/10  2 (0-8)/13 
  Nitroglycerin  1 (0-5)/11   1 (0-2)/12   1 (0-5)/15   1 (0-2)/12 
Fluid input, mL  1800 (1300-1800)1 1800 (900-1800) 1400 (750-1800) 1650 (1250-1800) 
Diuresis, mL  435 (90-1350)  385 (150-1440) 435 (120-1050) 529 (90-1350) 
 
Median (ranges) or number (N) where appropriate. Abbreviations: HES = hydroxyethyl starch; CABG = 
coronary artery bypass grafting; OPCABG = off pump coronary artery bypass grafting; AVR = aortic 
valve replacement; ASD = atrial septal defect; AAA = abdominal aortic aneurysm; TAA = thoracic aortic 
aneurysm; MS = mesenteric stenosis; CPB = cardiopulmonary bypass; APACHE = acute physiology 
and chronic health evaluation; AP<0.05 between colloid groups; 1P<0.005 saline versus colloids.  
 
The inclusion criteria, judged when the patients arrived at the ICU, were presumed 
hypovolemia, defined as a systolic blood pressure below 110 mm Hg and reduced 
filling pressures: a pulmonary capillary wedge pressure (PCWP) at or below 10 mm 
Hg in the presence of a pulmonary artery catheter (n=49) and proper wedging (n=36) 
or a central venous pressure (CVP) at or below 8 mm Hg (n=31). At actual 
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enrollment and start of the protocol, PCWP had to be below 13 and CVP below 12 
mm Hg. Patients were thus only included if they had or needed, on clinical grounds, 
arterial and pulmonary artery or central venous catheters. Exclusion criteria were: 
age >79 years and known anaphylactoid reactions to colloids.  
 
On the day of surgery, anesthesia was induced by sufentanil, pancuronium and 
midazolam and maintained by a continuous infusion of propofol with supplemental 
bolus doses of sufentanil. Radial artery, central venous and, if indicated on clinical 
grounds, pulmonary artery catheters were inserted for hemodynamic measurements 
and blood sampling. After tracheal intubation, the lungs were volume-controlled 
ventilated with a tidal volume of 8-10 mL/kg resulting in an end-tidal CO2 
concentration between 4 and 5%, using an O2-air mixture with an inspiratory O2 
concentration of 40%. A positive end-expiratory pressure (PEEP) of 5 cm H2O was 
applied. 31 cardiac surgery patients and 5 major vascular surgery patients underwent 
surgery with help of a cardiopulmonary bypass (CPB) or a left-left shunt, respectively 
(Stockert-Sorin S3, Sorin Biomedica, Mirandola, Modena, Italy). The extracorporeal 
bypass was primed with Ringer’s lactate, gelatin 4%, mannitol, sodium bicarbonate, 
aprotinin and heparin. After systemic heparinization, extracorporeal blood flow was 
started, provided that the activated clotting time was prolonged. Non-pulsatile flow 
rate was maintained at 2-3 L/min/ m2. Cardiac surgery patients were cooled to 32 °C 
nasopharyngeal temperature. Mean arterial pressure (MAP) was maintained at 50-80 
mm Hg and if the MAP declined to less than 50 mm Hg, the blood flow rate was 
increased and/or vaso-active drugs were given. After aortic cross-clamping, all 
cardiac surgery patients received crystalloid cardioplegia for myocardial protection (in 
total, 2000 mL, potassium 16 mmol/L, 4 °C). Patients were weaned from the 
CPB/left-left shunt, using inotropic support, if necessary. 
 
After termination of bypass, heparin was neutralized using an equivalent dose of 
protamine sulphate (3 mg/kg or 1 mg/kg). Autologous blood and residual volume 
from the extracorporeal circuit were infused as first-choice fluid administration. 
Guided by low systemic and filling pressures, saline or colloids were infused 
additionally. If the hemoglobin concentration was less than 6 mmol/L, packed red 
 79 
blood cells concentrates were infused. At the end of the surgery, a 4F introducing 
sheath (Arrow, Reading, USA) was inserted into the femoral artery, for use in the 
study protocol, in 33 cardiac and 21 major vascular surgery patients. All peri-
operative care was given by physicians unaware of group assignment, independently 
from the study protocol. 
Study protocol. At the arrival of the patients in the intensive care unit, the study 
protocol was started. The hospital pharmacy allocated the patients, via the sealed 
envelope method, to the various groups. Demographics were recorded, including the 
acute physiology and chronic health evaluation (APACHE-II) score and baseline (t=0 
min) measurements of hemodynamics were performed and blood samples taken. 
Pressures were measured with patients in the supine position after calibration and 
zeroing to atmospheric pressure at midchest level (TramscopeR, Marquette, Wisc., 
USA). The CVP and PCWP were taken at end-expiration, the latter after balloon 
inflation. For the reproducible measurement of the cardiac preload indicator global 
end-diastolic volume (GEDV, n 700-900 mL/m2), the transpulmonary thermal indicator 
dilution technique was used (12,26-31). The measurement involves a central venous 
injection of 15 mL of an ice-cold 5% glucose solution and concomitant registration of 
the thermal dilution in the femoral artery, with help of a 3F catheter equipped with a 
thermistor (PV 2024, Pulsion Medical Systems, Munich, Germany), inserted at the end 
of surgery via a 4F introducing sheath (Arrow, Reading, USA) and connected to a 
bedside computer (COLD Z-021, Pulsion Medical Systems, Munich, Germany). 
Thermodilution measurements of GEDV and cardiac output (mL/min) were done in 
duplicate and averaged values were taken (31). The ratio between stroke volume and 
GEDV/4 is the global ejection fraction (GEF, n 25-35%), an indicator of systolic cardiac 
function (27,30). Arterial and pulmonary artery (n=49) or central venous (n=18) blood 
samples were obtained for determinations of hemoglobin/hematocrit, partial O2 
pressure and the O2 content (Sysmex SE-9000, Sysmex Corporation, Kobe, Japan, 
and Rapidlab 865, Bayer Diagnostics, Tarrytown, NY, USA), lactate and albumin levels 
(Roche/Hitachi 747, Roche Diagnostics Corporation, Indianapolis, USA) and the COP 
(membrane osmometer, Osmomat 050, Gonotec, Berlin, Germany, molecular mass 
cut-off at 20 kDa). After baseline measurements (t=0 min), fluids were dosed during 90 
min on the basis of the response within predefined pressure limits, as measured by the 
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pulmonary artery catheter or central venous catheter according to the protocol depicted 
in Table 1, as described in the literature (35), and targeting at maximum CVP and 
PCWP values of 13 and 15 mm Hg, respectively. The maximum amount of fluid 
infused was thus 1800 mL. In some instances, the PA catheter failed to wedge during 
fluid loading, so that fluid challenge was guided by PCWP in 36 of 49 patients with PA 
catheters (9 saline group, 6 gelatin group, 9 HES group and 12 albumin group 
patients) and by CVP in the remaining 31 patients. In the PCWP-guided patients, the 
CVP was also measured at the time points of the study. Every 30 min, from t=0 to 90 
min, cardiac output and GEDV were measured. Blood samples were taken at t=0 and 
90 min. Concomitant treatment such as doses of vasoactive and sedative drugs and 
ventilatory settings was unchanged during fluid loading. The pulmonary effects of this 
trial have been published elsewhere (36).  
Calculations and statistical analysis. The study had 82% power to detect a 
statistically significant difference (at two-sided P<0.05) in a fluid loading-induced 
increase in CI, the main study parameter, of 10% (standard deviation of 26%), in saline 
(n=16) and 32% (standard deviation 25%) in the colloid-loaded patients (n=51). 
Cardiac output was indexed to body surface area (BSA), yielding cardiac index (CI, 
L/min/m2). This was also done for GEDV, yielding GEDVI (mL/m2). Left ventricular 
stroke work index (LVSWI, gm/m2) was calculated as stroke volume x (mean arterial 
pressure-PCWP) x 0.0136/BSA. Stroke volume index (SVI) is stroke volume/BSA. In 
patients in whom only CVP was available, PCWP was substituted for by CVP, since 
increases in CVP and PCWP were similar (rs=0.61, P<0.001). The relation between 
LVSWI and GEDVI is denoted as preload-recruitable stroke work. O2 delivery and 
consumption were calculated according to standard formulae. We calculated plasma 
volume changes from (Hb0/Hb90) - ((1-Hct90)/(1-Hct0)), in which Hb is hemoglobin 
and Hct hematocrit, measured at 0 and 90 min (37). Data are summarized as median 
and range, except in the figures where means and standard errors of the mean (SEM) 
are used, for clarity. The X2 test was used for categorical variables. We tested for 
changes between t=90 and t=0 in the group as a whole (Wilcoxon signed-rank test). 
Differences in baseline variables and/or changes between colloid and saline groups 
were evaluated with the Mann-Whitney U test and the Kruskal-Wallis non-parametric 
test was used to evaluate differences among the colloid groups. Groups were also 
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compared in t=90 min values in SVI, CI and LVSWI. The Friedman test was used to 
evaluate multiple time-dependent changes, available for CVP, PCWP, CI and GEDV, 
measured at t=0, 30, 60 and 90 minutes. The non-parametric Spearman rank 
correlation coefficient was used to express relations. A P<0.05 was considered 
statistically significant, but lower levels of statistical significance were also reported. 
 
 
Table 3. Laboratory data 
    
       NaCl 0.9%  Gelatin 4%  HES 6%   Albumin 5%  
       n=16     n=16   n=17    n=18 
 
Hemoglobin, mmol/L 
t=0    6.0 (4.2-7.5)  5.8 (4.3-7.7)  6.0 (3.7-8.9)  5.5 (4.4-9.1) 
t=90A    6.0 (4.7-7.2)1 5.1 (4.0-6.4)  5.0 (3.7-7.5)  4.9 (4.3-7.8) 
Plasma volume change, % 
t=0-90    3 (-18-24)1  20 (-8-49)  21 (-11-50)  15 (2-43)  
Albumin, g/ L 
t=0    22 (14-30)  22 (14-27)  22 (12-27)  21 (15-28) 
t=90    23 (12-28)  19 (11-25)C  17 (9-24)C  35 (28-42)C 
Colloid osmotic pressure, mm Hg 
t=0    16.8 (10.5-20.6) 17.9 (13.3-21.1) 18.1 (13.5-24.9) 18.1 (13.0-23.8) 
t=90A    15.4 (9.5-22.9)1 19.8 (18.3-24.7) 21.7 (17.5-25.5) 21.2 (15.0-25.8) 
pH 
t=0    7.40 (7.28-7.47) 7.40 (7.26-7.46) 7.42 (7.32-7.52) 7.40 (7.33-7.46) 
t=90A    7.36 (7.26-7.46) 7.40 (7.27-7.44)B 7.41 (7.30-7.47)B 7.39 (7.26-7.46)B 
Temperature, °C 
t=0    36.3 (34.9-37.1) 35.9 (34.9-36.6) 35.6 (34.5-37.2) 35.6 (35.0-37.1) 
t=90A    36.4 (34.8-37.3) 36.2 (35.3-37.2) 35.9 (35.1-38.4) 36.0 (35.1-37.9) 
 
Median (range); AP<0.001 (for change in whole group); BP<0.05, CP<0.001 (for changes among colloid 
groups); 1P<0.001 (for changes in saline versus colloid groups)  
 
 
RESULTS 
 
Clinical data. Table 2 shows the patient characteristics: there was a slight imbalance 
in sex distribution among the groups. In the cardiac surgery patients, the number of 
grafts (median and ranges) were 4 (1-6) in patients receiving saline, 4 (2-6) patients 
receiving gelatin, 4 (3-7) patients receiving HES and 4 (1-5) patients receiving 
albumin (ns between groups). During the study protocol, more saline than colloid fluid 
solution was infused. Patients had an uneventful recovery except for one cardiac 
surgery patient in the gelatin group, who eventually died from postoperative 
complications (cerebral infarction), and one vascular surgery patient in the saline 
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group, who died one day post-operatively from re-bleeding. Both events were judged 
not to relate to fluid loading. 
Laboratory data (Table 3). Baseline values did not differ. There was a slight 
difference in changes of pH from t=0 till t=90 between colloid groups. The blood 
hemoglobin/hematocrit decreased in the colloid versus the saline groups, together with 
the arterial O2 content (data not shown), indicative of greater hemodilution. Increases 
in plasma volume were greater in colloid than in saline groups. The albumin content 
decreased in gelatin and HES groups and increased in the albumin group. The COP 
decreased in the saline and increased in the colloid groups. The arterial PO2 ranged 
between 66 and 220 mm Hg at baseline, but there were no changes or differences 
between groups, at similar levels of FiO2 and PEEP (data not shown).  
Hemodynamics (Table 4). Baseline values did not differ. For all patients together 
MAP, SVI, CI, GEF and LVSWI increased together with increases in CVP, PCWP and 
GEDVI. Systemic vascular resistance decreased. Within the group as a whole, heart 
rate remained constant, although between colloid and saline groups the change in 
heart rate slightly differed. Time-dependent increases in CVP and PCWP from t=0, 30, 
60 to 90 min were statistically significant in all groups (P<0.005), for GEDVI only in the 
albumin group (P<0.001). Concomitantly with less CVP increase in saline than in 
colloid groups (Table 4, Fig. 1), CI only increased in the colloid groups versus the 
saline group. LVSWI increased in all groups (P<0.05). The SVI increased from median 
38 mL/min/m2 in the saline group and from 44-46 mL/min/m2 in the colloid groups (ns) 
up to 42 mL/min/m2 in the saline and up to 51-55 mL/min/m2 in the colloid groups, 
values being different between the colloids and saline at t=90 (P<0.01). Also, the t=90 
min CI and LVSWI differed between saline and colloid groups (P<0.05, ns among 
colloid groups). Fig. 1 and 2 show that the increase in filling pressure/volume and CI 
differed among the groups, with the smallest increase in the saline-loaded group. Fig. 
3 shows that the slope of the LVSWI/GEDVI relation did not differ, suggesting similar 
cardiac function among groups. The slopes of the relations between filling pressures 
and GEDVI (compliance) did not differ among the groups either (not shown).  
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Table 4. Hemodynamic data 
 
       NaCl 0.9%   Gelatin 4%  HES 6%   Albumin 5%  
       n=16     n=16   n=17    n=18 
 
Heart rate, beats/min 
t=0    78 (55-93)  71 (46-98)  68 (55-88)  70 (46-101) 
t=90    70 (56-93)1  72 (54-86)  70 (57-87)  80 (40-96) 
Mean arterial pressure, mm Hg 
t=0    73 (63-102)  72 (52-84)  80 (59-113)  75 (57-107) 
t=90A    83 (66-109)  83 (56-97)  89 (67-121)  85 (62-118) 
CI, L/min/ m2 
t=0    3.0 (2.1-4.5)  3.1 (2.2-4.8)  2.7 (1.6-4.4)  3.0 (2.4-4.7) 
t=90A    3.1 (1.8-5.8)2 3.9 (3.5-4.8)  3.9 (2.8-6.2)  3.8 (2.6-5.9) 
CVP, mm Hg 
t=0    4 (1-12)  4 (0-8)  3 (0-7)  5 (1-9) 
t=90A    5.5 (2-13)3  7.5 (3-11)  7 (4-12)  8 (4-12) 
PCWP, mm Hg  n=9   n=6   n=9   n=12 
t=0    6 (4-13)  7.5 (3-10)  7 (3-11)  7 (1-10) 
t=90A    9 (5-15)1  11.5 (7-14)  12.5 (9-15)  11 (8-14) 
GEDVI, mL/m2  n=14   n=10   n=14   n=16   
t=0     894 (614-1131) 944 (755-1331) 908 (584-1563) 842 (537-1149) 
t=90A    896 (650-1230) 1030 (652-2527) 939 (575-1731) 994 (603-1205) 
GEF, % 
t=0    18 (11-30)  23 (11-26)  21 (13-27)  19 (14-41) 
t=90A    19 (13-31)  25 (14-28)  23 (16-31)  22 (17-37) 
LVSWI, gm/m2 
t=0    37 (27-66)  42 (21-65)  43 (24-97)  39 (30-76) 
t=90A    40 (24-123)1  57 (34-80)  59 (38-83)  54 (28-106) 
 
Median (range); CI = cardiac index; CVP = central venous pressure; PCWP = pulmonary capillary wedge 
pressure; LVSWI = left ventricular stroke work index; GEDVI = global end-diastolic volume index; GEF = 
global ejection fraction; P<0.001 (for change in whole group); 1P<0.05, 2P<0.005, 3P<0.001 (for changes 
in saline versus colloid groups). 
 
 
Predictors of CI response. Fig. 4 shows the individual relations between changes in 
plasma volume and GEDVI versus those in CI and similar relations applied for SVI 
changes. It is shown that colloid fluid loading resulted in greater increases in plasma 
volume and GEDVI, determining the CI response, than saline fluid loading, except for 
one outlier in the saline group. In stepwise linear regression analysis, the CI response 
depended on the type of fluid, irrespective of baseline values of GEDVI, MAP and 
filling pressures. 
O2 balance (Table 5). Baseline values did not differ. O2 delivery and consumption 
increased similarly among groups. Venous oxygen saturation and lactate levels did not 
change.  
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DISCUSSION 
 
After elective cardiac or major vascular surgery, 90 min of filling pressure-guided fluid 
loading with colloid solutions results in a greater preload-recruitable CI and LVSWI 
than that with saline loading. Greater fluid responsiveness can be explained by a 
greater plasma volume expanding effect associated with an increase in COP, rather 
than by changes in cardiac function. Artificial colloids are equally effective as albumin, 
at least at roughly iso-oncotic concentrations. 
 
Table 5. O2 balance 
     
       NaCl 0.9%   Gelatin 4%  HES 6%   Albumin 5%    
       n=16     n=16   n=17    n=18 
 
O2 delivery, mL/min/m2 
t=0    486 (215-767) 454 (318-576) 397 (215-556) 415 (299-1044) 
t=90A    512 (219-984) 505 (342-581) 452 (296-685) 476 (254-1116) 
O2 consumption, mL/min/m2 
t=0    103 (26-158)  118 (62-192)  113 (78-243)  127 (53-200) 
t=90A    145 (73-187)  161 (70-268)  137 (59-203)  138 (89-226) 
Venous O2 saturation 
t=0    0.75 (0.65-0.95) 0.73 (0.63-0.90) 0.75 (0.57-0.83) 0.73 (0.47-0.86) 
t=90    0.73 (0.68-0.88) 0.73 (0.60-0.83) 0.78 (0.65-0.87) 0.75 (0.51-0.86) 
Lactate, mmol/L 
t=0     1.4 (0.6-4.1)  1.2 (0.7-2.6)  1.1 (0.5-3.4)  1.1 (0.5-3.0) 
t=90    1.4 (0.7-4.1)  1.2 (0.7-3.4)  1.2 (0.5-2.9)  1.0 (0.5-2.9) 
 
Median (range); AP<0.001 (for change in whole group) 
 
 
Our study carries the advantage of comparing multiple, common types of 
resuscitation fluids in standardized fluid challenge protocol, which has not been done 
in prior studies on cardiac or vascular surgery, either utilizing fixed volume boluses or 
prolonged (>8 h to days) filling pressure-guided fluid resuscitation (3-20). Moreover, 
the number of fluids or patients included in earlier studies was generally lower than in 
ours (3-20). Prior to fluid challenge, our patients had evidence for hypovolemia, e.g. 
relatively low CVP and PCWP, which, otherwise, may overestimate true filling 
pressures in the presence of positive airway pressure at the end of expiration. 
Moreover, most patients were dependent on vasopressors. The baseline GEDVI may 
have been normal, but may still be associated with hypovolemia and preload 
recruitability in patients with cardiac dysfunction and the need for dilatation to 
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maintain CI, described after cardiac surgery (26-29,31).  
 
The hemodiluting and plasma volume expanding effects of colloids were greater than 
those of saline, even though the total amount of fluids used was somewhat greater 
for saline. That saline loading somewhat decreased heart rate as compared to 
colloids can be attributed to the greater volume, at room temperature, passing the 
heart during infusion, since relatively cold infusion fluids may have a negative 
chronotropic effect. 
The similar slopes of preload-recruitable CI and LVSWI support similar cardiac 
systolic function among the fluid groups (30). The GEDVI measurements also 
confirmed the filling pressure responses (Fig. 2). These measurements were 
included since fluid-filled catheter-derived filling pressures have traditionally been 
used and are still widely employed as indicators of cardiac preload and fluid 
responsiveness, while filling pressures may be inferior to filling volumes in this 
respect (12,26-31). The difference in fluid responsiveness between crystalloid and 
colloid fluids can thus be attributed to differences in cardiac filling rather than in 
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Figure 1. Mean ± SEM for cardiac index (CI) versus filling pressure (CVP, central venous pressure) 
in the various groups (Panel A: saline; panel B: gelatin; panel C: hydroxyethyl starch; panel D: 
albumin), at the 4 time points of fluid loading (t=0 , t=30 , t=60 , and t=90  min). Baseline CI 
did not differ and increases were only statistically significant in gelatin, hydroxyethyl starch and 
albumin groups (P<0.001).  
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cardiac function. The lack of saline loading to increase CI and LVSWI can be easily 
explained by saline extravasating in the course of time during the fluid challenge 
upon transient increases in filling pressures.  
 
Our results confirm the hitherto controversial view that colloid solutions are better 
retained intravascularly because of their colloid osmotic properties and therefore 
result in greater and faster plasma volume expansion and fluid responsiveness of CI 
and LVSWI than saline. Indeed, there is one recent study showing that the 
intravascular retention of albumin is greater than that of saline after cardiac surgery, 
as inferred from measurements of plasma and extravascular fluid volumes (14).  
 
 
A study comparing dextran and saline in vascular surgery patients demonstrated the 
importance of a colloid solution to maintain the intravascular volume, measured with 
radiolabeled albumin (19). Our study confirms earlier trials comparing crystalloid with 
colloid fluid resuscitation after cardiac surgery and vascular surgery suggesting that 
more crystalloid than gelatin, starch or dextran is needed to maintain cardiac output 
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Figure 2. Mean ± SEM for cardiac index (CI) versus global end-diastolic volume index (GEDVI) 
in the various groups (Panel A: saline; panel B: gelatin; panel C: hydroxyethyl starch; panel D: 
albumin), at the 4 time points of fluid loading (t=0 , t=30 , t=60 , and t=90  min). Baseline 
values and slopes did not differ.  
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(8,10,12,15,17,20). Our study contrasts with studies showing similar volumes and 
hemodynamic effects of crystalloids and colloids after surgery (6) and the recent 
SAFE study on albumin 4% versus saline fluid resuscitation in intensive care unit 
patients, showing only minimally greater intravascular volume expanding effects of 
albumin at only slightly greater saline requirements (25). However, cardiac surgery 
patients were excluded in this study and there was no rigid fluid challenge protocol 
with hemodynamic monitoring, potentially masking differences in fluid properties and 
hemodynamic actions.  
 
 
 
 
 
 
 
 
It has been suggested that the heart during and after cardiac surgery is susceptible for 
myocardial edema and for postischemic systolic and diastolic dysfunction (38). Colloid 
solutions used to prime the cardiopulmonary bypass system could ameliorate such 
effect (38,39) and postoperative administration of hyperoncotic albumin may thus have 
a positive inotropic effect, as compared to saline (13). On the other hand, the rise in CI 
with albumin appeared less than with saline at similar filling pressures in a study in 
vascular surgery patients (16), and this difference can be explained by either 
Figure 3. Mean ± SEM for preload-recruitable stroke work (LVSWI, left ventricular stroke work) 
in saline (), gelatin (), hydroxyethyl starch () and albumin () -loaded patients with global 
end-diastolic volume index (GEDVI) on the x-axis (from t=0 to 90 min only). Baseline values and 
slopes did not differ among groups, while the LVSWI attained differed (P=0.021) between 
saline and colloid groups. 
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insufficient preload or perhaps by the negative inotropic effect of calcium binding by 
albumin (33), which was otherwise not evident in our study. By measuring filling 
volumes in addition to filling pressures, changes in myocardial diastolic and systolic 
function could be assessed in our study (12,26-31). There was no change in the slope 
of the filling pressure to GEDVI relation, suggesting no differences in myocardial 
compliance and therefore in myocardial edema among the groups, even though COP 
was higher in colloid-loaded patients. Hence, our results do not indicate, at least after 
cardiac surgery in man, that starch ameliorates ischemia/reperfusion injury of the heart 
and resultant myocardial edema, as in animal models of myocardial injury (34). In our 
study, there was no clear hemodynamic difference among the colloid solutions, so that 
non-protein colloid solutions could substitute for protein-based solutions, at least in the 
acute treatment of hypovolemia, thereby agreeing with some studies (3,4,5). This does 
not confirm some other trials, suggesting hemodynamic inferiority of protein versus 
non-protein colloid fluids (7,9,11,32). The differences may partly relate to imprecise 
hemodynamic monitoring, rather than on major differences in hemodynamic actions of 
iso-oncotic colloid fluids, even though the number of patients in our study, adequately 
powered to detect CI differences among saline and colloid fluids, may have been 
insufficient to find small differences among the latter. 
 
Figure 4. Changes in cardiac index (CI) versus changes in plasma volume (left panel) and global end-
diastolic volume index (GEDVI) (right panel): rs=0.49, P<0.001 and rs=0.64, P<0.001, respectively. It is 
shown that saline loading increased PV, GEDVI and thus CI less than colloid loading. 
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Both DO2 and VO2 increased in our patients during fluid loading, in the presence of 
normal lactate levels. Together with the postoperative rise in temperature, this 
suggests that the increase in VO2 and thus in DO2 was caused by a rise in O2 demand 
rather than by VO2 supply-dependency (40). Some caution is warranted, however, as 
the ranges of DO2 changes may have been insufficient to rule out mathematical 
coupling and a spurious relation between DO2 and VO2 (40). The drawback of 
expansion of plasma volume is hemodilution (14), so that O2 delivery increases did not 
differ among fluid types. In any case, the increase in CI measured at 90 min after 
completion of the protocol was still greater in colloid than in saline-loaded patients 
(P=0.01, data not shown) and such sustained effects in CI have been associated with 
shorter durations of stay of major surgery patients (2,10,21). 
 
In conclusion, our study suggests that, during 90 min of pressure-guided fluid loading 
to augment preload, fluid responsiveness is greater with colloid than saline fluids in 
presumably hypovolemic patients after cardiac or major vascular surgery. This 
supports the idea that the plasma COP is operative clinically, independently of blood 
albumin concentrations, in retaining fluids intravascularly. 
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ABSTRACT 
 
Background. The optimal type of fluid for treating hypovolemia without evoking 
pulmonary edema is still unclear, particularly in the presence of pulmonary vascular 
injury, as may occur after cardiac and major vascular surgery.  
Methods. In a single-centre, prospective, single-blinded clinical trial 67 mechanically 
ventilated patients were randomly assigned to receive saline, gelatin 4%, HES 6% or 
albumin 5%, according to a 90 min fluid loading protocol with target central venous 
pressure of 13 mm Hg and pulmonary capillary wedge pressure of 15 mm Hg, within 
three hours after cardiac or major vascular surgery. Before and after the protocol, we 
recorded hemodynamics and ventilatory variables and took chest radiographs. The 
pulmonary vascular injury was evaluated with help of the 67Ga-transferrin pulmonary 
leak index (PLI) and extravascular lung water (EVLW). Plasma colloid osmotic 
pressure (COP) was determined and the lung injury score (LIS) was calculated. 
Results. More saline was infused than colloid solutions (P<0.005). The COP 
increased in the colloid groups and decreased in patients receiving saline. Cardiac 
output rose more in the colloid groups. At baseline, PLI and EVLW were above 
normal in 60% and 30% of the patients, with no changes after fluid loading, except 
for a greater PLI decrease in HES than in gelatin-loaded patients. The oxygenation 
ratio improved in all groups. In the colloid groups, the LIS increased, because of a 
decrease in total respiratory compliance, probably associated with a rise in 
intrathoracic plasma volume.  
Conclusions. Provided that fluid overloading is prevented, the type of fluid used for 
volume loading does not effect pulmonary permeability and edema, in patients with 
acute lung injury after cardiac or major vascular surgery, except for HES that may 
ameliorate increased permeability. During fluid loading, changes in LIS (and 
respiratory compliance) do not represent changes in permeability-edema. 
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INTRODUCTION 
 
Hypovolemia is common in the critically ill and various infusion fluids are available for 
treatment (1). These include crystalloid and colloid fluids, which, in theory, promote 
and limit fluid extravasation in the lungs and formation of pulmonary edema, 
respectively, since the former lower and the latter maintain or even increase plasma 
colloid osmotic pressure (COP). The so called colloid-crystalloid controversy includes 
the relative propensity of fluid types to evoke pulmonary edema, which is not yet 
settled in the absence of direct permeability and edema measurements in most 
studies (1). Indeed, the controversy is complicated by the idea that the potentially 
protective role of COP may diminish when permeability is increased, while the 
propensity for edema formation may increase, unless hydrostatic pressure is kept 
low, as demonstrated in experimental and human studies (2-4). In the recent SAFE 
study, resuscitation of critically ill (non-cardiac surgery) patients with albumin or 
saline proved almost equally safe without differing mortality rates, although 
pulmonary edema was not studied specifically (5).  
 
Cardiac and major vascular surgery are often complicated by hypovolemic 
hypotension, necessitating fluid therapy, but the optimal type of fluid for this purpose 
is hotly debated (1,6-13). Cardiac and major vascular surgery, involving ischemia 
and reperfusion, are well known risk factors for a systemic inflammatory response 
and for acute lung injury/acute respiratory distress syndrome (ALI/ARDS), associated 
with increased capillary permeability in the lungs in some patients, as measured by a 
non-invasive double radionuclide technique to detect pulmonary 67Ga-transferrin 
extravasation (14-18). This could thus affect the contribution of infusion fluids to 
pulmonary edema formation. Indeed, studies documented a rise in extravascular 
lung water (EVLW) after cardiac or major vascular surgery and fluid loading, at least 
transiently in some patients (9-11,19-22).  
 
Finally, experimental studies suggest that middle and large molecular solutions of 
starches may ‘plug’ the leaks during increased permeability after ischemia/ 
reperfusion, endotoxemia, toxic injury or extracorporeal bypass (23-27). They may 
 96 
even improve pulmonary dysfunction after aortic surgery in humans (28). Moreover, 
albumin solutions may have an anti-inflammatory antioxidant effect, thereby 
ameliorating endothelium-neutrophil interactions in the lungs and increased 
permeability in experimental studies (29). Infusion fluids may thus affect capillary 
permeability in the human lungs. 
 
We hypothesized that colloid fluid loading would less aggravate edema formation in 
the lungs than saline loading, in the treatment of presumed hypovolemia after major 
surgery, even if complicated by increased pulmonary permeability. We also 
hypothesized that hydroxyethyl starch or albumin loading would lower increased 
permeability edema, as compared to gelatin loading. We therefore compared filling 
pressure-guided fluid challenges (30) with saline and with the colloids gelatin, 
hydroxyethyl starch (HES) and albumin in their effects on pulmonary capillary 
permeability, EVLW, COP, and the lung injury score in 67 presumably hypovolemic 
patients after cardiac or major vascular surgery. 
 
PATIENTS AND METHODS 
 
This study is a prospective, stratified, randomized, single-blinded and single-centre 
clinical trial. The study was approved by the Ethical Committee of the Vrije 
Universiteit Medical Center. Written informed consent was obtained in each of the 89 
eligible patients, on the day prior to scheduled surgery. The hospital pharmacy 
assigned the patients randomly, via the sealed envelop method, to various groups, 
after stratification between cardiac (n=40) or major vascular surgery (n=28). Of the 
89, 68 patients fulfilled the study criteria at the arrival at the intensive care unit (ICU) 
post-operatively. One cardiac patient assigned to saline, however, was excluded 
because of technical failures and one patient assigned to the gelatin group 
inadvertedly received albumin. Hence, 67 consecutive patients were included in the 
study. The inclusion criteria, judged when the patients arrived at the ICU, were 
presumed hypovolemia, defined as a systolic blood pressure below 110 mm Hg and 
reduced filling pressures: a pulmonary capillary wedge pressure (PCWP) at or below 
10 mm Hg in the presence of a pulmonary artery catheter (n=49) and proper wedging 
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(n=36) or a central venous pressure (CVP) at or below 8 mm Hg (n=31). Patients 
were thus only included if they had or needed, on clinical grounds, arterial and 
pulmonary artery or central venous catheters. Exclusion criteria were: age >79 years 
and known anaphylactoid reactions to colloids or iodide. On the day of surgery, 
anesthesia was induced by sufentanil, pancuronium and midazolam and maintained 
by a continuous infusion of propofol with supplemental bolus doses of sufentanil. 
Radial artery, central venous and, if indicated on clinical grounds, pulmonary artery 
catheters were inserted for hemodynamic measurements and blood sampling. After 
tracheal intubation, the lungs were volume-controlled ventilated with a tidal volume of 
8-10 mL/kg resulting in an end-tidal CO2 concentration between 4 and 5%, using an 
O2-air mixture with an inspiratory O2 concentration of 40%. A positive end-expiratory 
pressure (PEEP) of 5 cm H2O was applied. Cardiac surgery patients received 50-100 
mg dexamethasone at induction. Thirty-one cardiac surgery patients and 5 major 
vascular surgery patients underwent surgery with help of a cardiopulmonary bypass 
(CPB) or a left-left shunt, respectively (Stockert-Sorin S3, Sorin Biomedica, 
Mirandola, Modena, Italy). The extracorporeal bypass was primed with Ringer’s 
lactate, gelatin 4%, mannitol, sodium bicarbonate, aprotinin and heparin.   
 
After systemic heparinization, extracorporeal blood flow was started, provided that 
the activated clotting time was prolonged. Non-pulsatile flow rate was maintained at 
2-3 L/min/m2. Cardiac surgery patients were cooled to 32 °C nasopharyngeal 
temperature. Mean arterial pressure (MAP) was maintained at 50-80 mm Hg and if 
the MAP declined to less than 50 mm Hg, the blood flow rate was increased and/or 
vaso-active drugs were given. After aortic cross-clamping, all cardiac surgery 
patients received crystalloid cardioplegia for myocardial protection (in total, 2000 mL, 
potassium 16 mmol/L, 4 °C). Patients were weaned from the CPB/left-left shunt, 
using inotropic support, if necessary and heparin was neutralized using an equivalent 
dose of protamine sulphate (3 mg/kg or 1 mg/kg). Autologous blood and residual 
volume from the extracorporeal circuit were infused as first-choice fluid 
administration. Guided by low systemic and filling pressures, saline or colloids were 
infused additionally. If the hemoglobin concentration was less than 6 mmol/L, packed 
red blood cells concentrates were infused. Pre-operative use of aspirin, excessive 
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bleeding and a long pump-time prompted for administration of donor platelets. At the 
end of the surgery, a 4F introducing sheath (Arrow, Reading, USA) was inserted into 
the femoral artery, for use in the study protocol, in 33 cardiac and 21 major vascular 
surgery patients. 
 
Table 1. Patient characteristics 
 
    NaCl 0.9%  Gelatin 4% HES 6%  Albumin 5%   
    n=16  n=16  n=17  n=18 
 
Age, year   64 (53-75)  63 (41-75)  66 (38-74)  62 (51-74)  
Sex, M/F   14/2   16/0a   10/7a   14/4a  
APACHE II    8 (3-17)  8 (2-18)  9 (2-14)  9 (3-15) 
Cardiac surgery  9   9   10   11 
Major vascular surgery 7   7   7   7 
Type of surgery    
  CABG   4   4   6   6  
  OPCABG   2   2   2   2 
  AVR    1   0   1   2 
  CABG + AVR  2   2   0   1 
  ASD repair   0   1   1   0 
  AAA    6   7   2   4 
  TAA    1   0   3   1 
  MS    0   0   2   2 
CPB, min/N   122 (86-188)/8 96 (85-190)/7 111 (40-168)/11 115 (77-198)/10 
Aortic clamping time, min/N 
    95 (43-140)/14 90 (31-175)/14 76 (26-102)/13 70 (49-113)/14 
Inotropic support, µg/kg/min/N 
  Dopamine   2 (0-17)/10  2 (0-8)/14  0.5 (0-10)/10 2 (0-8)/13 
  Nitroglycerin  1 (0-5)/11  1 (0-2)/12  1 (0-5)/15  1 (0-2)/12 
Fluid infused, mL  1800 (1300-1800)b 1800 (900-1800)  1400 (750-1800)  1650 (1250-1800) 
Diuresis, mL   435 (90-1350)  385 (150-1440) 435 (120-1050)  529 (90-1350) 
 
Median (ranges) or number (N) where appropriate. Abbreviations: HES = hydroxyethyl starch; 
APACHE = acute physiology and chronic health evaluation; CABG = coronary artery bypass grafting; 
OPCABG = off pump coronary artery bypass grafting; AVR = aortic valve replacement; ASD = atrial 
septal defect; AAA = abdominal aortic aneurysm; TAA = thoracic aortic aneurysm; MS = mesenteric 
stenosis; CPB = cardiopulmonary bypass; aP<0.05 between colloid groups, b P<0.005 saline versus 
colloids. 
 
Measurements. For the measurement of the pulmonary leak index (PLI), as done in 
previous studies (14-16), autologous red blood cells were labeled with 
99mTechnetium (Tc, 11 MBq, physical half-life 6h; Mallinckrodt Diagnostica, Petten, 
The Netherlands) Transferrin was labeled in vivo, following i.v. injection of 67Gallium 
(Ga)-citrate, 4.5 MBq for the pre-infusion study and 9 MBq for the post-infusion study 
(physical half-life 78 h; Mallinckrodt Diagnostica, Petten, The Netherlands). Patients 
were in the supine position and two scintillation detection probes (Eurorad C.T.T., 
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Strasburg, France) were positioned over the right and left lung apices. Starting at the 
time of the i.v. injection of 67Ga, radioactivity was detected during 30 minutes. The 
99mTc and 67Ga counts were corrected for background radioactivity, physical half-life, 
spill-over of 67Ga into the 99mTc window, obtained by in vitro measurement of 67Ga, 
and expressed as counts per minute (CPM) per lung field. At 1, 5, 8, 12, 16, 20, 25 
and 30 minutes after 67Ga injection, blood samples (2 mL aliquots) were taken. Each 
blood sample was weighed and radioactivity was determined with a single well well-
counter (LKB Wallac 1480 WIZARD, Perkin Elmer, Life Science, Zaventem, 
Belgium), taking background, spillover of 67Ga into 99mTc and decay into account. 
Results were expressed as CPM/g. For each blood sample, a time-matched CPM 
over each lung was taken. A radioactivity ratio was calculated, (67Galung/99mTclung)/ 
(67Gablood/99mTcblood), and plotted against time. The PLI was calculated from the slope 
of increase of the radioactivity ratio divided by the intercept, to correct for physical 
factors in radioactivity detection. The PLI represents the transport rate of 67Ga-
transferrin from the intravascular to the extravascular space of the lungs and is 
therefore a measure of pulmonary vascular permeability. The values for both lung 
fields were averaged. The upper limit normal for the PLI is 14.7 x 10-3/min and the 
measurement error is about 10% (14,16).  
 
For the measurement of cardiac output (CO), intrathoracic blood volume (ITBV) and 
extravascular lung water (EVLW), the transpulmonary thermal-dye dilution technique 
was used (22,31). This involves a central venous injection of a dye and thermal 
bolus, 15 mL of 1 mg/mL indocyanine green (ICG) in a ice-cold dextrose 5% solution 
and concomitant registration of the dye dilution and thermal shift in the femoral 
artery, with help of the 3F catheter equipped with a thermistor and fiberoptic (PV 
2024, Pulsion Medical Systems, Munich, Germany) connected to a bedside 
computer (COLD Z-021, Pulsion Medical Systems, Munich, Germany). The catheter 
was introduced via the introducing sheath. Measurements were done in duplicate, 
irrespective of the ventilatory cycle, and average values were taken. The technique 
yields the transpulmonary thermodilution CO, and a transit time of the dye in the 
thorax and thereby the ITBV. From the differences in transit time of the thermal and 
dye signal, the EVLW is computed (31). The upper limit of normal for the EVLW is 7 
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mL/kg and the measurement error is about 10%. In overt pulmonary edema, the 
EVLW is usually doubled. In the absence of a thermal-dye dilution femoral artery 
catheter, CO was measured by thermodilution via the pulmonary artery catheter 
since this is almost interchangeable with transpulmonary measurements (31,32). We 
calculated plasma volume changes from (Hb0/Hb90) - ((1-Hct90)/(1-Hct0)), in which 
Hb is hemoglobin and Hct hematocrit, measured at 0 and 90 min (33).  
Protocol. After surgery, the patients were admitted to the ICU, and connected to the 
ventilator (Evita 3, Dräger, Lübeck, Germany) and volume-controlled ventilation was 
started with similar settings as during surgery. The study protocol was started within 
three hours after arrival. Demographics were recorded, including variables to the 
acute physiology and chronic health evaluation (APACHE-II) score and baseline 
measurements of the 67Ga-transferrin PLI (t=-30 to t=0 min) and hemodynamics 
were performed and an anteroposterior chest radiograph was taken. Pulmonary and 
systemic hemodynamic variables were measured after calibration and zeroing to 
atmospheric pressure at mid-chest level (TramscopeR, Marquette, Wisc., USA). 
Mean pulmonary artery pressure (MPAP), CVP and, after balloon inflation, the 
PCWP were taken at end-expiration, with patients in the supine position. Arterial and 
pulmonary artery (n=49) or central venous blood samples (n=18) were obtained for 
determinations of Hb/Hct (Sysmex SE-9000, Sysmex Corporation, Kobe, Japan) and 
partial O2 pressure/saturation (Rapidlab 865, Bayer Diagnostics, Tarrytown, NY, 
USA). The COP was measured by a membrane osmometer (Osmomat 050, 
Gonotex, Berlin, Germany, molecular cut-off at 20 kDa). Venous admixture was 
calculated from arterial, mixed (or central) venous and capillary O2 contents, 
calculated from hemoglobin, O2 pressures and saturations, according to standard 
formulae. The inspiratory O2 fraction (FiO2), PEEP (cm H2O), tidal volume and 
inspiratory plateau pressure were taken from the ventilator. The total respiratory 
compliance was calculated from tidal volume/(plateau pressure-PEEP), mL/cm H2O. 
The chest X-ray was scored by a consultant radiologist, blinded to the study, who 
evaluated the number of quadrants with alveolar consolidations, ranging from 0 to 4. 
To further document the severity of the pulmonary abnormalities, a lung injury score 
(LIS) was calculated, taking into account the level of PEEP, the arterial PO2/FiO2 
ratio, to total respiratory compliance and the number of quadrants with alveolar 
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consolidations on the chest radiograph (34). The score ranges from 0 to 4, with 
values below 2.5 denoting ALI and above 2.5 ARDS.  
 
Patients had been randomly assigned to NaCl 0.9%, GelofusineR (gelatin 40g/L, B. 
Braun Melsungen AG, Germany, in 154/120 mmol/L NaCl), HES 6% (MW 200.000, 
substitution 0.45-0.55, HemohesR, B. Braun Melsungen AG, Germany, in saline) or 
albumin 5% (100 mL Cealb 20%, Sanquin, CLB, Amsterdam, The Netherlands, 
diluted in 300 mL of saline). After baseline measurements, fluids were given during 
90 min on the basis of the response within predefined pressure limits, on the basis of 
the PCWP after appropriate wedging (n=36) or the central venous pressure (n=31), 
according to a fluid challenge protocol described in the literature (ref. 30, Figure 1) 
and targeting to a maximum PCWP of 15 mm Hg and a CVP of 13 mm Hg. Boluses 
of maximum 200 mL were given per 10 min, so that the maximum fluid challenge 
was 1800 mL in 90 min. Concomitant treatment, including ventilatory settings and 
administration of vasoactive and sedative drugs was unchanged. The measurements 
were repeated immediately after completing the fluid challenge (t=90 min). Diuresis 
 
 
 
CVP (up to 13 mm Hg) or 
PCWP (up to 15 mm Hg):    t=0: 
CVP ≤ 8 mm Hg or 
PCWP ≤ 10 mm Hg: 
200 mL/min 
 
10 minutes later: 
2 < ↑ < 5 mm Hg CVP or 
3 < ↑ < 7 mm Hg PCWP: wait 10 minutes 
↑ > 5 mm Hg CVP or 
↑ > 7 mm Hg PCWP: stop 
↑ ≤ 2 mm Hg CVP or 
↑ ≤ 3 mm Hg PCWP: continue 
t= 90: STOP 
 
 
 
 
 
CVP ≤ 8 mm Hg or  CVP < 12 mm Hg or  CVP = 12 mm Hg or 
PCWP ≤ 10 mm Hg  PCWP < 14 mm Hg  PCWP = 14 mm Hg 
 
 
 
200 mL/10 min   100 mL/10 min   50 mL/10 min 
During 
resuscitation:  
↑ > 5 mm Hg CVP 
or 
Figure 1. Fluid challenge protocol (modified from reference 30). 
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was recorded. 
Statistical analysis. The CO and ITBV were indexed to body surface area, yielding 
cardiac index (CI) and intrathoracic blood volume index (ITBVI), respectively. EVLW 
was expressed as EVLW/kg body weight. Since we were primarily interested in the 
effect of colloid and the intrinsic effects of HES and albumin, we evaluated with help 
of the non-parametric Mann Whitney U test if there were statistically significant 
differences between saline and (pooled) colloid fluid loading, and between HES or 
albumin versus gelatin loading. Baseline and changes from baseline were evaluated, 
after studying changes in the whole group with help of the paired non-parametric 
Wilcoxon signed rank test. We have indicated four levels of significance, P<0.05, 
0.01, 0.005 and 0.001 to account for multiple testing. Spearman rank correlation 
coefficients were used to express relations. Data are presented as median and 
range. The study was powered to detect a PLI and EVLW difference between saline 
(n=14) and colloid fluid resuscitation (n=40) of 22% (at a standard deviation of 25%), 
at two-sided α=0.05 and ß=0.80. 
 
RESULTS 
 
Patient characteristics. Patient characteristics are listed in Table 1. Patients had an 
uneventful recovery except for one cardiac surgery patient in the gelatin group, who 
eventually died from postoperative complications (cerebral infarction), and one 
vascular surgery patient in the saline group, who died one day post-operatively from 
re-bleeding. Both events were judged not to relate to fluid loading. Groups were 
comparable, except for sex distribution. Except for one patient with ARDS (LIS >2.5, 
in the saline group) all patients had ALI. More saline than colloid fluid was 
administered.   
Hemodynamic and biochemical variables. There were no baseline differences. 
Fluid loading increased CVP, MPAP (n=49) and PCWP (n=36) ( P values in Table 2). 
CVP and PCWP changes interrelated (rs=0.61, P<0.001). CI increased more in the 
colloid than in the saline groups. Saline loading decreased COP and colloid loading 
increased it. Hct decreased in the colloid groups and remained unchanged in the 
saline group, so that plasma volume rose more in the former.  
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Table 2. Hemodynamic and biochemical changes 
 
    NaCl 0.9%  Gelatin 4% HES 6%  Albumin 5%  
    n=16  n=16  n=17  n=18 
 
CVP, mm Hg 
 t=0  4 (1-12)  4 (0-8)  3 (0-7)  5 (1-9) 
 t=901  5 (2-13)c  7 (3-11)  7 (4-12)  8 (4-12) 
PCWP, mm Hg  n=9   n=6   n=9   n=12 
 t=0  6 (4-13)  7 (3-10)  7 (3-11)  7 (1-10) 
 t=901  9 (5-15)a  11 (7-14)  12 (9-15)  11 (8-14) 
MPAP, mm Hg  n=12   n=11   n=13   n=13 
 t=0  16 (11-23)/12 16 (9-19)/11  16 (12-28)/13 17 (8-22) 
 t=901  17 (12-29)c  22 (14-26)  24 (17-35)  22 (15-26) 
CI, L/min/m2 
 t=0  3.0 (2.1-4.5)  3.1 (2.2-4.8)    2.7 (1.6-4.4)  3.0 (2.4-4.7) 
 t=901  3.1 (1.8-5.8)b 3.9 (3.5-4.8)  3.9 (2.8-6.2)  3.8 (2.6-5.9) 
ITBVI, mL/min/m2  n=14   n=10   n=14   n=16 
  t=0  1119 (689-1371) 1171 (938-1605) 1177 (716-1953) 1049 (641-1387) 
 t=901  1150 (793-1513) 1277 (852-3315) 1181 (772-2164) 1189 (741-1530) 
COP, mm Hg 
 t=0  16.8 (10.5-20.6) 17.9 (13.3-21.1) 18.1 (13.5-24.9) 18.1 (13.0-23.8) 
 t=901  15.4 (9.5-22.9)c 19.8 (18.3-24.7) 21.7 (17.5-25.5) 21.2 (15.0-25.8) 
Hemoglobin, mmol/L 
   t=0  6.0 (4.2-7.5)  5.8 (4.3-7.7)  6.0 (3.7-8.9)  5.5 (4.4-9.1) 
 t=901   6.0 (4.7-7.2)c 5.1 (4.0-6.4)  5.0 (3.7-7.5)  4.9 (4.3-7.8) 
Hematocrit 
  t=0  0.28 (0.20-0.35) 0.28 (0.21-0.35) 0.28 (0.17-0.42) 0.26 (0.20-0.42) 
 t=901  0.28 (0.22-0.34)c 0.24 (0.18-0.29) 0.24 (0.16-0.36) 0.23 (0.20-0.37) 
Change in plasma volume, % 
 t=0-90 3.0 (-17.5-24.5)c 19.6 (-7.7-49.4) 20.5 (-10.8-49.6) 14.9 (2.3-42.6) 
 
Median (ranges) or number (N) where appropriate. Abbreviations: CVP = central venous pressure; 
PCWP = pulmonary capillary wedge pressure; MPAP = mean pulmonary artery pressure; CI = cardiac 
index; ITBVI = intrathoracic blood volume index; COP = colloid osmotic pressure; 1P<0.001 for whole 
group at t=90 versus t=0 min; aP<0.05, bP<0.005, cP<0.001 for change in saline versus colloids. 
 
Pulmonary leak index and extravascular lung water. Technical problems 
precluded PLI measurements in 3 patients. EVLW (and ITBV) measurements were 
available in 14 patients in the saline, 10 patients in the gelatin, 14 patients in the 
HES and 16 patients in the albumin group. Baseline PLI and EVLW were above 
normal in 9 (56%) and 5 (31%) of patients in the saline group, 7 (44%) and 2 (13%) 
of patients in the gelatin group, 13 (76%) and 5 (29%) of patients in the HES group 
and 11 (61%) and 8 (44%) of patients in the albumin group, and cardiac and major 
vascular surgery patient groups did not differ. The baseline PLI was thus above 
normal (> 14.7 x 10-3/min) in 40 of 67 (60%) patients and the baseline EVLW in 20 of 
67 (30%) patients, without significant group differences. The PLI decrease in HES 
was greater than in the gelatin group (Figure 2). Whereas EVLW declined for all 
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groups together (P<0.05), the change did not differ between saline and colloid fluid 
resuscitation, whether the PLI was elevated or not (Figure 3). The changes in EVLW 
directly correlated with changes in PCWP (rs=0.43, P<0.05).  
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Respiratory variables (Table 3). At baseline, the FiO2 in the saline group was 50 
(39-62), in the gelatin group 41 (37-61), in the HES group 41 (39-60) and in the 
albumin group 40 (38-60)% (NS). The PEEP at baseline was 6 (5-15), 7 (5-12), 5 (4-
10) and 7 (5-16) cm H2O and the tidal volumes were 600 (500-730), 580 (450-740), 
571 (400-730) and 566 (395-1110) mL, in the saline, gelatin, HES and albumin 
groups, respectively (NS). During fluid loading, the PvO2, PaO2 and oxygenation ratio 
increased in all groups, while the PaCO2 (not shown) did not change. In the patients 
receiving colloids, a small elevation in LIS was associated with a decrease in total 
respiratory compliance. The fall in compliance correlated with the rise in ITBVI 
(rs=0.28, P<0.05). 
 
 
 
Figure 2. Box and whisker plots of changes in pulmonary leak index (PLIt=90-PLIt=0, x 103.min-1) 
in the various resuscitation fluid groups within cardiac surgery patients and vascular surgery  
patients. There was no difference among groups, except for a greater decline in the HES than  
the gelatin group (P<0.05). Values in boxes are at 25th percentile, median and 75th percentile  
(= interquartile range, IQR); whiskers are values <1.5 IQR and extremes (*, at >3 IQR),  
where appropriate. 
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Table 3. Respiratory variables 
 
   NaCl 0.9%  Gelatin 4%  HES 6%  Albumin 5%  
   n=16   n=16   n=17   n=18 
 
Temperature, °C 
 t=0  36.3 (34.9-37.1) 35.9 (34.9-36.6) 35.6 (34.5-37.2) 35.6 (35.0-37.1) 
 t=904  36.4 (34.8-37.3) 36.2 (35.3-37.2) 35.9 (35.1-38.4) 36.0 (35.1-37.9) 
PaO2, mm Hg 
 t=0  127 (87-172) 116 (70-185) 130 (66-220) 113 (76-189) 
 t=902  142 (82-195) 131 (78-190) 143 (82-217) 134 (74-179) 
PvO2, mm Hg 
 t=0  41 (30-75)  40 (31-54)  36 (24-50)  38 (28-50) 
 t=902  40 (36-51)  38 (33-88)  41 (27-46)  40 (30-64) 
PaO2/FiO2, mm Hg 
 t=0  279 (140-430) 281 (121-463) 289 (110-537) 263 (127-485) 
 t=904  337 (164-488) 324 (134-475) 308 (161-529) 333 (123-459) 
Venous admixture  
 t=0  0.21 (0.10-0.62) 0.19 (0.09-0.40) 0.17 (0.04-0.34) 0.16 (0.05-0.40) 
 t=90  0.16 (0.09-0.32) 0.16 (0.06-0.38) 0.19 (0.06-0.36) 0.16 (0.07-0.36) 
Plateau pressure, cm H2O 
 t=0  18 (13-28)  18 (12-26)  18 (14-22)  18 (14-33) 
 t=903  18 (14-28)  20 (12-27)c  19 (15-28)c  18 (14-26)c 
Total respiratory compliance, mL/cm H2O 
 t=0  63 (28-91)  49 (35-94)  50 (38-71)  53 (31-91) 
 t=904  64 (26-91)a  48 (32-91)  46 (25-64)  53 (27-79) 
Radiology number, quadrants 
 t=0   0 (0-3)  1 (0-3)  0 (0-3)  0 (0-1) 
 t=901  0 (0-4)  0.5 (0-4)  1 (0-3)  1 (0-3) 
Lung injury score  
 t=0  1.00 (0.25-2.75) 1.12 (0.25-2.00) 1.00 (0.25-2.00) 0.75 (0.25-2.00) 
 t=901  1.00 (0.25-2.75)b 1.25 (0.50-2.75) 1.00 (0.50-2.25) 1.00 (0.25-2.50) 
EVLW, mL/kg 
 t=0  6.1 (4.8-13.2) 5.9 (3.7-20.0) 6.7 (2.5-13.8) 6.8 (2.1-10.3) 
 t=901  6.1 (3.9-13.3) 5.2 (4.0-21.5) 6.2 (3.2-12.1) 6.2 (1.5-13.0) 
PLI, x 10-3/ min 
 t=0  15 (6-101)  14 (6-73)  24 (11-81)  20 (7-60) 
 t=90  15 (10-50)  15 (10-98)  20 (9-48)d  21 (7-103) 
 
Median (ranges) or number (N) where appropriate. Abbreviations: PO2 = partial pressure of O2 in 
arterial (a) or venous (v) blood; FiO2 = inspiratory O2 fraction; EVLWI = extravascular lung water index; 
PLI = pulmonary leak index; 1P<0.05, 2P<0.01, 3P<0.005, 4P<0.001 for whole group at t=90 versus t=0 
min; aP<0.05, bP<0.001 for change in saline versus colloids; cP<0.01 for change between colloid 
groups; dP<0.05 for change between gelatin and HES. 
 
 
DISCUSSION 
 
Many patients after cardiac or major vascular surgery had some degree of ALI, 
associated with increased permeability, edema, and ventilatory and radiographic 
abnormalities in the lungs. While fluid overloading was prevented, the changes were 
not affected by loading with saline, gelatin, HES or albumin. However, HES 
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attenuated increased permeability. Nevertheless, the LIS slightly increased in the 
colloid groups, associated with a fall in total respiratory compliance. 
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In our study, 60% of the patients had an increase in the PLI directly after surgery, 
confirming that cardiac and major vascular surgery are risk factors for capillary injury 
and ALI (14-18). Indeed, 30% of the patients had an EVLW of more than 7 mL/kg 
directly after surgery, agreeing with the literature, showing a moderate and transient 
increase in EVLW in some patients after cardiac or major vascular surgery (9,10,19-
22,31). 
 
Since diuresis was similar, the EVLW did not change in either group and plasma 
volume increased less in the saline group than in the colloid groups, the 
extrapulmonary extravascular fluid volume must have been higher in the saline group 
than in the colloid groups. Hence, the plasma COP increase in colloid-treated 
patients was effective in keeping colloid fluids, at least temporarily within the plasma 
volume compartment with less extravasation into the extrapulmonary extravascular 
Figure 3. Box and whisker plots of changes in extravascular lung water (EVLWt=90-EVLW t=0) 
in the various resuscitation fluid groups within cardiac and vascular surgery patients. There 
was no difference between groups, while for all patients together EVLW decreased (P<0.05). 
Values are at 25th percentile, median and 75th percentile (IQR); whiskers are values <1.5 
IQR and outliers (1.5 <outlier (○) <3 IQR), where appropriate. 
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space, as compared to saline loading. The rise in systemic venous pressure was 
apparently able to increase fluid extravasation in the systemic circulation during fluid 
loading, which was limited by a concomitant increase in COP in the patients 
receiving colloids. Apparently, COP remained operative, even though it is widely 
accepted that cardiac surgery evokes a systemic inflammatory response and cardiac 
and vascular surgery are accompanied by ischemia/reperfusion, contributing to an 
increase in capillary permeability (14,15,18). Increased extravascular accumulation 
of saline as compared to colloid fluids apparently did not include the lungs.  
 
The lack of effect of COP on PLI and EVLW in our study agrees with the findings by 
Sibbald and co-workers (2), describing transvascular small and large molecular 
tracer flux in ALI/ARDS patients, loaded with albumin, and the predominant effect of 
hydrostatic pressure rather than of COP on these fluxes, at least when permeability 
was severely increased, as in the experimental oleic acid model (4). That 
transvascular albumin transport increased with albumin loading in their study but not 
in ours, can be explained, since the PLI method in our study takes intravascular 
albumin mass and surface area into account and is a specific measure of 
permeability independent of bulk flow (14). Our results do not agree with 
experimental studies showing a benefit of colloid versus saline fluid loading 
regarding edema formation in injured lungs (3). In contrast to those studies, the 
increase in permeability may have been more severe in our patients, or hydrostatic 
pressures promoting edema formation may have been lower than in the experiments, 
or both. Otherwise, the unchanged PLI during a rise in CI may agree with the 
literature showing that an increase in CI does not increase protein permeability in the 
isolated dog lung (35). Although lung water may increase with increased CI and 
surface area available for exchange in the isolated dog lung (35), lung edema is CI-
independent when evaluated in the in vivo lung injured by oleic acid or in humans 
after cardiac surgery (32,36). In our study, a maximum PCWP of 10-15 mm Hg, at a 
PEEP of 4-16 cm H2O, was well tolerated, even though the changes in EVLW 
between t=0 and 90 min directly correlated with changes in PCWP rather than with 
changes in PLI or COP. The latter indeed suggests an important role of hydrostatic 
pressure in the formation of pulmonary edema in ALI after major surgery and the 
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protective role of avoiding high filling pressures on the formation of edema, even 
when permeability is increased and COP is lowered. Conversely, our results show 
the safety of the fluid challenge protocol (30), whether CVP or PCWP are used. 
Indeed, the fair interrelation between CVP and PCWP changes in our patients 
agrees with the literature (37). 
 
In spite of an increased oxygenation ratio, the LIS slightly but significantly increased, 
but more in colloid groups than in the saline group, because of a greater decline in 
total respiratory compliance in the colloid groups. Since changes in compliance were 
associated with changes in ITBVI that includes pulmonary blood volume, a fall in 
compliance may relate to greater pulmonary intravascular filling with colloids. Indeed, 
volume loading in pigs decreased total respiratory compliance, and exsanguination 
of dogs/pigs increased pulmonary compliance due to a loss of pulmonary blood 
volume (38,39). Finally, the greater rise in CI in the colloid groups versus the saline 
group can be explained by greater expansion of the plasma volume tending to 
elevate the ITBVI, determining the preload of the heart (22,31), with colloids than 
with crystalloids. These disparate hemodynamic effects agree with the literature, 
showing that crystalloids were less effective expanders of plasma volume and in 
boosting cardiac output after cardiac or major vascular surgery, than colloids 
(6,8,9,11,13,22,40). The increase in arterial PO2 can be explained by a rise in 
venous PO2, concomitantly with a rise in CI and tissue oxygenation, at constant 
venous admixture, and to the concomitant slight fall in EVLW with time (41). 
Alternatively, the increase in PO2 may be associated with opening up of 
postoperatively increased atelectatic areas, with increasing airway pressures.  
 
Finally, there is evidence in our study that HES favourably affects pulmonary 
permeability, independent of COP, in ALI after cardiac surgery or major vascular 
surgery. This agrees with experimental studies, suggesting that middle and high 
molecular weight starch molecules may ameliorate lung injury and permeability-
edema under a variety of circumstances, including ischemia/reperfusion, 
endotoxemia, toxic injury and extracorporeal bypass (23-27). Rittoo and co-workers 
described better pulmonary function after aortic surgery in patients treated with HES 
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than with gelatins, but did not study permeability or edema directly (28). Some 
caution is warranted, however, as some patients underwent thoracic procedures in 
the HES group and baseline PLI tended to be somewhat higher than in the gelatin 
group. We could not confirm the experimental observations that albumin solutions 
have antioxidant properties and may ameliorate endothelial-neutrophil interactions in 
the lungs and permeability edema (29). Since our study was primarily powered to 
detect a difference between saline and colloid fluid loading, the number of patients 
studied may have been too small to demonstrate a small specific effect of albumin.  
 
Although having the advantage of a multiple comparison among fluids in a relatively 
large patient group and independent measurements of permeability and edema, our 
study carries some limitations. The study was not investigator-blinded. Fluid 
resuscitation was guided by filling pressures, which is common practice since 
hydrostatic pressures are important determinants of EVLW. However, we believe 
that the conclusion that EVLW does not depend on the type of fluid given within this 
range of hydrostatic pressures is clinically relevant. We cannot exclude however, that 
more saline would have been needed and more EVLW had developed, as compared 
to colloid fluid, if fluid loading had been guided by filling volumes (ITBV) rather than 
pressures. Thermal-dye EVLW may be underestimated when focal lung injury is 
accompanied by regional hypoperfusion (42). However, the underestimation and CI-
dependency of EVLW in hypoperfused areas may be minimal in less severe, indirect, 
lung injury in humans as opposed to animal models of ARDS (32,42). There are only 
few studies utilizing direct measurements of EVLW, often with help of old techniques 
and ex vivo dye concentration measurements, and their response to multiple fluids 
after cardiac or major vascular surgery (9-11,19,20,22,31). In other studies, only 
surrogate indicators of pulmonary edema have been used (6-8,12,13,28,40). The 
number of fluids evaluated in the studies has often been limited to two or three, so 
that the potential intrinsic properties of fluids could not be easily separated from 
effects caused by COP changes. Gallagher and co-workers compared saline, HES 
and albumin (n=5 in each group) postoperatively and did not find differences in 
EVLW (elevations) (10). Karanko and co-workers compared dextran (n=14) with 
Ringer's acetate (n=18) for fluid loading after cardiac surgery and found that EVLW 
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did not increase in both groups, while gas exchange transiently deteriorated in the 
dextran group (11). Wahba and co-workers found that gelatin loading (n=11) 
increased ITBVI and thus CI more than Ringer's solution (n=11) after cardiac 
surgery, without affecting EVLW, as in our study (22). Studying aortic surgery 
patients, Shires and co-workers compared Ringer’s lactate with a colloid 
(plasmanate) in 18 patients during surgery, and despite differences in COP, EVLW 
after surgery did not differ (9). As in our study, this can be explained by the relatively 
low filling pressure attained (9). Our study thus extends some of these previous 
studies and may conform the conclusion from meta-analyses that the type of fluid 
used for treating hypovolemia does not effect pulmonary edema formation, provided 
that fluid overloading is avoided.  
 
In conclusion, saline or colloids do not affect permeability-edema in ALI after cardiac 
or major vascular surgery, provided that fluid overloading is avoided, except for HES 
that may ameliorate increased permeability. The LIS, however, may slightly increase 
after colloid versus saline loading, because of greater intrathoracic plasma volume 
expansion decreasing total respiratory compliance, thus indicating that changes in 
LIS (and respiratory compliance) during fluid loading do not represent changes in 
permeability-edema.  
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FIRST PART: Pulmonary dysfunction in the critically ill 
 
In the first part of this thesis, we studied the incidence and pathogenesis of pulmonary 
dysfunction in three subsets of patients at risk for developing acute lung injury (ALI) 
and adult respiratory distress syndrome (ARDS), i.e. post-operative cardiac surgery 
patients (chapter 2), major vascular surgery patients (chapter 3) and septic patients 
(chapter 4). We focused on the relative contribution to acute lung injury of pulmonary 
edema and increases in endothelial permeability, measured as the efflux of 
radiolabelled transferrin by the pulmonary leak index (PLI), in relation to oxygenation 
and radiological abnormalities.  
 
In patients after cardiac surgery and major vascular surgery and in septic patients, 
gas exchange, lung mechanical abnormalities and a fall in oxygenation were not 
directly related to the presence of extravascular lung water (EVLW). Moreover, 
supranormal values of the pulmonary leak index (PLI) were not associated with more 
radiographic densities, mechanical abnormalities or lower oxygenation levels after 
cardiac or major vascular surgery. However, in septic patients, particularly if 
associated with pneumonia, increases in pulmonary microvascular permeability were 
present together with more radiographic pulmonary densities, higher values of 
shunting and cardiac index and lower oxygenation ratios, independently of EVLW or 
the presence of atelectasis. 
 
An increase in pulmonary microvascular permeability, as measured by the PLI, might 
be transient, particularly after uncomplicated surgery (1). Indeed, 44% of the patients 
after cardiac and 69% of the patients after major vascular surgery had an increase in 
PLI. However, no sustained pulmonary complications occurred and all but two 
patients were discharged from the ICU the next morning, suggesting that increased 
permeability was transient in these patients. In contrast, all septic patients had a 
supranormal PLI, as well as higher values of PLI and more sustained ventilatory 
problems, related to more severe microvascular injury. Moreover, high levels of PLI 
were associated with a higher mortality rate in septic patients.  
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Increases in EVLW were found in approximately 30% of the post-operative cardiac and 
aortic surgery patients, and in 68% of the septic patients, but EVLW was not 
associated with outcome. Moderate increases in extravascular lung water however, 
may be located in interstitial areas not important for gas exchange, thereby explaining 
the absence of a direct relationship between the moderate increases in EVLW and gas 
exchange, as seen in our patients.  
 
The importance of the colloid osmotic pressure in preventing the development of lung 
edema decreases in the presence of an increase in pulmonary microvascular 
permeability, as the colloid-osmotic gradient between the intravascular and interstitial 
compartments decreases. This explains our finding that the COP related to the amount 
of EVLW in postoperative cardiac surgery patients, but not in the vascular surgery and 
septic patients, the latter groups having a higher incidence and higher levels of PLI. In 
the vascular surgery patients a direct relationship was found between increases in 
microvascular permeability (PLI) and the development of EVLW, but this remained 
without direct consequences on gas exchange. The absence of a relationship between 
the PLI and EVLW in the other groups may be due to pulmonary protection 
mechanisms to prevent the development of lung edema, including an increase in 
lymph flow for instance, together with changes in interstitial hydrostatic and colloid 
osmotic pressures.  
 
Absent relationships between the EVLW and PLI on the one hand and gas exchange 
and radiological abnormalities on the other hand point towards a role of atelectasis 
and/or consolidations in disturbing gas exchange. Indeed, atelectasis found after 
cardiac surgery was associated to higher levels of venous admixture, higher levels of 
positive end-expiratory pressure (PEEP) and oxygen inspiratory fraction (FiO2). 
Atelectasis was described to occur in almost all patients undergoing general 
anesthesia and intraoperative or perioperative lung recruitment may improve 
outcome (2). In the septic group of patients however, patients with and without 
atelectasis did not differ in gas exchange variables or number of quadrants with 
alveolar densities. In these patients, venous admixture related to the degree of 
microvascular injury (PLI), and in patients with pneumonia higher values of PLI were 
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found as compared to extrapulmonary sepsis, together with more extensive 
radiographic densities, higher venous admixture and cardiac index and lower 
oxygenation ratios. 
 
Conclusion 
Acute lung injury and the adult respiratory distress syndrome are conditions with a 
multi-factorial pathogenesis (Fig. 1). Measurement of interstitial edema (EVLW) and 
pulmonary microvascular permeability in the critically ill are valuable tools in 
evaluating the severity of the disease and their relative contribution to pulmonary 
dysfunction. Although pulmonary edema and microvascular injury are common after 
cardiac and major vascular surgery, atelectasis is, at least in part, determining 
radiological and ventilatory abnormalities and may be treated with lung recruitment 
maneuvers. However, in patients with sepsis, particularly if associated with 
pneumonia, increased venous admixture and impaired oxygenation are better 
explained by a lung vascular injury, associated with alveolar consolidations bearing 
no relationship to the presence of edema or atelectasis. This may hamper alveolar 
recruitment and limit the effect of diuretics and may imply the need for anti-
inflammatory strategies. 
 
Figure 1. In the critically ill, acute lung injury and adult respiratory distress syndrome are conditions 
with a multi-factorial pathogenesis and characterized by radiological and gas exchange abnormalities, 
together with an increase in endothelial permeability. Patients with cardiac failure also may exhibit lung 
edema, radiological abnormalities and impaired oxygenation in the presence of an unchanged 
pulmonary leak index. Atelectasis and consolidations are not accompanied by increased PLI/EVLW or 
EVLW only, respectively. 
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SECOND PART: Fluid loading in the critically ill 
 
In patients with ALI, treatment consists of supportive strategies, including mechanical 
ventilation to improve gas exchange. Furthermore, hypovolemia is relatively common 
in these patients, resulting in a reduction in oxygen delivery, the latter depending on 
both cardiac output and arterial oxygen content. Resuscitation fluids are needed to 
increase cardiac output and consequently oxygen delivery. 
 
In the second part of the study, we evaluated the hemodynamic efficacy (chapter 5) 
of different resuscitation fluids relative to the pulmonary side effects (chapter 6). We 
studied the importance of the COP in plasma volume expansion and preventing 
pulmonary edema, together with possible intrinsic effects of fluids to influence 
myocardial contractility and microvascular permeability.  
 
Our findings in the second part of this thesis show that colloids by their effect on the 
plasma COP are more effective in expanding plasma volume than saline, resulting in 
a greater increase in preload-recruitable cardiac and left ventricular stroke work 
indices. This may be of importance since recent studies show that fluid therapy 
guided by left ventricular stroke work volume may improve outcome (3,4). Second, 
changes in plasma COP associated with fluid resuscitation of either colloids or 
crystalloids do not affect extravascular lung water differently.  
 
The major determinant of changes in EVLW appears to be a change in filling 
pressures, but at low levels of filling pressures no differences between the different 
fluid regimens were found. Since diuresis and the changes in EVLW were similar 
among groups and plasma volume increased less in the saline group than in the 
groups receiving colloids, the extrapulmonary extravascular fluid volume must have 
been higher in the patients receiving saline. This implies that the COP remains 
operative in the systemic circulation with less extravasation of colloids into the 
extrapulmonary extravascular space even in the presence of an increase in 
microvascular permeability. Moreover, this extravasation of saline explains why 
infusion of saline was less effective in increasing CI, LVSWI or filling pressures and 
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volumes as compared to infusion of colloids. The extravascular fluid accumulation of 
saline in the systemic circulation, but not in the pulmonary circulation may be 
explained by better protection mechanisms in the lungs, including an increase in 
lymph flow for instance. There was no change in the slope of the filling pressure to 
GEDVI relation, suggesting no differences in myocardial compliance and therefore in 
myocardial edema among the groups, even though COP was higher in colloid-loaded 
patients. These findings may imply that extravasation of saline occurs not in the 
myocardium or in the pulmonary interstitium, but in other organs and for example 
may cause intestinal edema (5). This is in line with the literature, in which organs 
were described to demonstrate large differences in capillary permeability, related to 
organ specific characteristics such as vascular reactivity, the degree of endothelial 
contraction and the composition of the capillary basement membrane (6).  
 
Our study also suggests that HES may favourably affect pulmonary permeability, 
independent of the COP in ALI after cardiac or major vascular surgery, although the 
levels of PLI were higher at baseline in the HES patients with three patients in the 
HES group undergoing thoracic-abdominal surgery versus none in the gelatin group. 
The protective effect of HES agrees with experimental data demonstrating that 
starch molecules ameliorate microvascular permeability (7-9). We did not find an 
effect of albumin on endothelial permeability, in contrast to others (8), but the 
number of patients studied may have been too small.  
 
Conclusions 
In the treatment of hypovolemia, colloid fluid loading leads to a greater increase in 
preload-recruitable cardiac and left ventricular stroke work indices than saline, 
because of greater volume expansion following an increase in plasma colloid 
osmotic pressure. Provided that fluid overloading is prevented, the type of fluid does 
not affect pulmonary permeability and edema in patients with acute lung injury after 
cardiac or major vascular surgery, except for HES that may ameliorate increased 
permeability. Fluid loading based on filling pressures is safe, as long as the filling 
pressures targeted are lower than the threshold pressure for edema formation.  
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Future perspectives 
Recent studies provide some evidence for the effectiveness of alternative 
approaches in the treatment of ALI/ARDS and measurement of EVLW and 
endothelial permeability may be valuable tools in the evaluation of new treatment 
strategies. In rats for instance, propofol was described to attenuate acute lung injury 
in an isolated rabbit-lung model (10) and anti-coagulant therapy was shown to 
attenuate the inflammatory response associated with I-R injury, thereby preventing 
organ dysfunction (11). Besides anti-inflammatory and anti-coagulant therapy, other 
treatment strategies include the administration of vasoactive drugs and promotion of 
alveolar fluid resorption (12). Perkins and coworkers demonstrated in a randomized 
trial that the use β-agonists in patients with ALI/ARDS, reduced lung water by 
increasing alveolar fluid resorption (13). Further research is needed to evaluate the 
short-term efficacy, together with the effects on outcome of these new treatment 
strategies in patients with acute lung injury, especially since ALI is associated with 
mortality in almost half of the patients (14). The precise contribution of atelectasis in 
different groups of critically ill also requires further study together with the evaluation 
of possible treatment strategies, including lung protective mechanical ventilation and 
lung recruitment.  
 
With respect to fluid loading, new challenges include the study of the intrinsic 
properties of fluids in the ICU setting with the available techniques, as our study in 
vivo and others in vitro (7-9) point towards a possible favorable effect of starches in 
preventing increases in microvascular permeability. 
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HART- EN LONGFUNCTIE VAN DE INTENSIVECAREPATIËNT EN HET EFFECT 
VAN VLOEISTOFBELASTING 
 
Eerste deel: Longfalen op de intensive care 
 
Longfalen is een veelvoorkomend probleem bij patiënten op de intensive care en 
wordt onder andere gekenmerkt door een verslechterde gasuitwisseling, afwijkingen 
op de röntgenfoto en longoedeem. Als longfalen plaatsvindt in de context van 
zogenaamde ‘acute lung injury’ (ALI), acute longschade, dan is een bijkomend 
kenmerk een verhoogde doorlaatbaarheid van de vaten ten gevolge van 
endotheelschade en kan de situatie uiteindelijk leiden tot het zogenaamde ’adult 
respiratory distress syndrome’ (ARDS). Risicofactoren op het ontstaan hiervan zijn 
sepsis, trauma, hart- en centrale vaatchirurgie. Algemeen wordt aangenomen dat het 
teveel aan longwater (longoedeem) de gasuitwisseling in de long duidelijk kan 
verstoren. Longoedeem in geval van ALI en ARDS wordt permeabiliteitsoedeem 
genoemd en moet worden onderscheiden van longoedeem ten gevolge van 
hartfalen, een situatie waarbij longoedeem ontstaat door een verhoogde 
hydrostatische druk, maar waarbij de doorlaatbaarheid van de vaten intact is. Dit 
onderscheid is belangrijk voor de therapie van de patiënt. Zo zal bij longoedeem 
door hartfalen de therapie gericht worden op verbetering van de hartfunctie. De 
verhoogde doorlaatbaarheid van het endotheel leidt tot een verhoogde flux van 
vloeistof en eiwitten van het vaatbed naar het interstitium, hetgeen kan leiden tot 
interstitieel oedeem. De doorlaatbaarheid van de vaten kan worden gemeten door 
middel van permeabiliteitsmetingen met gelabeld 67Gallium (Ga)-transferrine en 
99mTechnetium, hetgeen resulteert in een zogenaamde ‘pulmonary leak index’ (PLI). 
De snelheid waarmee 67Ga-transferrine lekt van het vaatbed naar het interstitium van 
de longen is dan een maat voor de doorlaatbaarheid van het vaatbed. In eerdere 
studies is reeds aangetoond dat met de PLI-meting men onderscheid kan maken 
tussen permeabiliteitsoedeem en cardiaal oedeem. De mate van longoedeem kan 
worden gemeten door middel van de verdunning van twee tracers in de 
longcirculatie. Eén tracer blijft intravasculair en een tweede verdeelt zich over zowel 
het intravasculaire als het interstitiële compartiment. Het verschil tussen de 
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verdelingsvolumina van beide tracers is een maat voor longoedeem.  
Alhoewel bij hart- en vaatchirurgiepatiënten, alsmede bij sepsispatiënten afwijkingen 
op de thoraxfoto, de aanwezigheid van longoedeem, een verhoogde 
doorlaatbaarheid van de longvaten en een verstoorde gasuitwisseling zijn 
aangetoond in eerdere studies, is de precieze bijdrage van longoedeem en 
endotheelschade aan de thoraxafwijkingen en gasuitwisselingsstoornissen niet goed 
in kaart gebracht. Daarbij komt dat afwijkingen op de thoraxfoto mede kunnen 
worden verklaard door bijvoorbeeld atelectase, gekenmerkt door ingeklapte 
longblaasjes, of de aanwezigheid van een intra-alveolair ontstekingsinfiltraat, zoals 
bij longontsteking. In beide situaties worden verdichtingen op de foto gezien en is de 
gasuitwisseling eveneens verstoord. 
 
In het eerste deel van dit proefschrift (hoofdstuk 2 tot en met 4) hebben we de 
incidentie van en relatie tussen longoedeem, endotheelschade, afwijkingen op de 
thoraxfoto en een verslechterde gasuitwisseling geëvalueerd bij patiënten met een 
verhoogd risico op het ontstaan van ARDS: hartchirurgie- en vaatchirurgiepatiënten 
en sepsispatiënten.  
 
De resultaten van ons onderzoek tonen aan dat bij een groot deel van alle 
bestudeerde patiënten een verhoogde doorlaatbaarheid wordt gezien van de 
longvaten, alsmede longoedeem en afwijkingen op de thoraxfoto met een 
verslechterde gasuitwisseling. Echter, zowel de endotheelschade als de 
aanwezigheid van longoedeem blijken niet bepalend te zijn voor de verstoorde 
gasuitwisseling of de radiologische afwijkingen. Met name bij postoperatieve hart- en 
vaatchirurgiepatiënten (hoofdstuk 2 en 3) speelt atelectase een rol in zowel de 
radiologische afwijkingen als de verslechterde gasuitwisseling, hetgeen impliceert 
dat beademingstechnieken om de dichtgeklapte longblaasjes te openen van nut 
zouden kunnen zijn voor de behandeling van een slechte gasuitwisseling. Bij de 
patiënten met sepsis is de primaire bron van infectie van belang. In hoofdstuk 4 
tonen we aan dat patiënten met sepsis ten gevolge van longontsteking meer 
verdichtingen op de thoraxfoto hebben, tezamen met meer endotheelschade en een 
slechtere gasuitwisseling, vergeleken met patiënten die een extrapulmonale bron 
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van infectie hebben. Atelectase, zoals gevisualiseerd op de röntgenfoto, bleek geen 
bepalende factor voor verschillen in deze variabelen tussen beide groepen. Dit 
impliceert dat bij de patiënten met longontsteking het openen van longblaasjes 
minder effectief zal zijn dan bij de sepsispatiënten met een infectiebron buiten de 
longen. Dit kan worden verklaard door de aanwezigheid van verdichtingen ten 
gevolge van directe intra-alveolaire schade met epitheelaantasting en aanwezigheid 
van een intra-alveolair ontstekingsinfiltraat bij longontsteking. Bij de overige 
sepsispatiënten leidt mogelijk een systemische ontstekingsreactie tot 
endotheelschade, met minder directe longschade aan de alveoli. De correlatie van 
de beademingsparameters met endotheelschade bij sepsispatiënten, met name in 
geval van longontsteking, betekent dat behandelingen met anti-inflammatoire 
middelen mogelijk de endotheelschade, en dus de gasuitwisseling en radiologische 
afwijkingen zouden kunnen verbeteren en dat van beademingsinstellingen minder 
effect kan worden verwacht. Het ontbreken van enige relatie tussen de 
gasuitwisseling en de hoeveelheid longoedeem in alle patiëntengroepen betekent 
dat weinig effect kan worden verwacht van de behandeling van longoedeem door 
middel van diuretica om de gasuitwisseling te verbeteren.  
 
Nieuwe behandelmethoden om longfalen tegen te gaan, zoals middelen die meer 
specifiek gericht zijn op het tegengaan van het ontstaan van endotheelschade, 
alsmede nieuwe beademingstechnieken bij postoperatieve patiënten kunnen in de 
toekomst worden geëvalueerd.  
 
Tweede deel: Vloeistofbelasting van de intensivecarepatiënt 
 
Op de intensive care worden patiënten onder andere ondersteunend behandeld met 
betrekking tot hart- en longfunctie. Dit betekent dat naast een optimale instelling van 
de beademing ook de hartfunctie moet worden geoptimaliseerd. Dit laatste kan door 
middel van het geven van vulling als het circulerend bloedvolume laag is of het 
geven van inotropica.  
 
Voor het corrigeren van een laag bloedvolume kunnen uiteenlopende vloeistoffen 
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worden toegediend. De belangrijkste zijn fysiologische vloeistoffen, zoals bijvoorbeeld 
fysiologisch zout of de zogenaamde colloïdale vloeistoffen. Colloïdale vloeistoffen 
kunnen worden onderverdeeld in albumineoplossingen of artificiële oplossingen, zoals 
gelatine- en zetmeeloplossingen. De vloeistoffen verschillen met betrekking tot de 
intrinsieke eigenschappen, zoals de concentratie en de halfwaardetijd in het lichaam. 
Eén van de belangrijkste discussiepunten is het belang van de colloïdaal osmotische 
druk. Sommige van de vloeistofsoorten, zoals de colloïdale vloeistoffen, kunnen een 
daling van de colloïdaal osmotische druk van het plasma tegengaan of zelfs verhogen. 
Een toename van de colloïdaal osmotische druk in het bloed zou kunnen leiden tot 
een snellere en effectievere toename van het bloedvolume en zou het ontstaan van 
interstitieel oedeem kunnen tegengaan. In geval van endotheelschade is de 
doorlaatbaarheid van de bloedvaten echter toegenomen en het belang van de 
colloïdaal osmotische druk neemt dan af. 
 
Onafhankelijk van de invloed op de colloïdaal osmotische druk, zijn van albumine en 
zetmeelproducten intrinsieke effecten beschreven op de doorlaatbaarheid van de 
bloedvaten. Met name tijdens in vitro-experimenten zijn er positieve invloeden van 
albumine en zetmeelproducten beschreven op de adhesie tussen leukocyten en het 
endotheel. Bovendien werd een mogelijk mechanische dichting van de poriën in het 
endotheel beschreven na toediening van zetmeelproducten, zodat de 
doorlaatbaarheid van de bloedvaten zou verminderen na de infusie van deze 
vloeistoffen. Bij patiënten zijn deze effecten op de doorlaatbaarheid van bloedvaten 
tot nu toe echter nauwelijks bestudeerd.  
 
In hoofdstuk 5 hebben we de effecten op korte termijn van vloeistoffen op de 
hartfunctie bestudeerd bij postoperatieve hart- en vaatchirurgiepatiënten. We hebben 
gekeken naar de invloed van een zoutoplossing, een gelatineoplossing, een 
zetmeeloplossing of een albumineoplossing op de vullingsdrukken en intrathoracale 
bloedvolumina, die bepalend zijn voor de cardiale vulling en uiteindelijk het 
hartminuutvolume. Patiënten kregen na randomisatie één van de vier verschillende 
infuusvloeistoffen toegediend. De vier groepen patiënten werden geanalyseerd met 
betrekking tot hartminuutvolume, cardiale vulling, systemische drukken en 
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vullingsdrukken. De colloïdale vloeistoffen resulteerden in een significante toename 
van de colloïdaal osmotische druk, met daarbij een snellere intravasculaire vulling, 
gemeten als toename van het globaal eind-diastolisch volume (GEDV) en het 
plasmavolume in vergelijking tot de patiënten die zout kregen toegediend. Bij deze 
laatste groep patiënten nam de colloïdaal osmotische druk af met een geringere 
toename van de intravasculaire vulling. De grotere toename van intravasculaire 
volumina bij patiënten die colloïdale vloeistoffen kregen toegediend resulteerde 
eveneens in hogere hartminuutvolumina. Tussen de drie colloïdale vloeistoffen 
onderling werden geen verschillen gevonden.  
 
In hoofdstuk 6 hebben we de effecten van dezelfde vloeistoffen op de longen 
bestudeerd. Er werd geen effect van de colloïdaal osmotische druk op de 
hoeveelheid longoedeem gemeten, ondanks een significante toename van de 
colloïdaal osmotische druk na toediening van colloïdale oplossingen en een afname 
na toediening van een zoutoplossing. De enige parameter die van invloed bleek op 
veranderingen in longoedeem was de intravasculaire hydrostatische druk in de 
longen, gemeten als wiggedruk. We concludeerden dat de hydrostatische druk de 
belangrijkste determinant van longoedeem is en dat bij lage wiggedrukken de 
colloïdaal osmotische druk niet van invloed is op de hoeveelheid longoedeem. Los 
van de invloed van de diverse vloeistoffen op de colloïdaal osmotische druk werd bij 
de patiëntengroep die een zetmeelproduct kreeg toegediend een daling in de 
hoeveelheid endotheelschade waargenomen in vergelijking met de groep die een 
gelatineproduct kreeg toegediend. Dit resultaat zou kunnen betekenen dat 
zetmeelproducten in vivo inderdaad vaatschade tegengaan.  
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